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Upper gastrointestinal haemorrhage is a common
medical emergency. At the Prince of Wales Hospital,
Hong Kong, upper gastrointestinal haemorrhage accounts
for 5% of all emergency admissions. Three quarters of
these patients are bleeding from peptic ulcers. While
the majority of patients with ulcer bleeding stop
bleeding spontaneously, approximately 20% continue to
bleed or develop rebleeding in hospital.
Until recently surgery was the only reliable method
of controlling the haemorrhage. With advances in
endoscopic techniques it is now possible to stop
bleeding with therapeutic endoscopy without resorting to
laparotomy. Methods which have been shown to be useful
include laser photocoagulation, electrocoagulation and
heat probe treatment.
There have been isolated reports of the use of
the local injection of sclerosants, with or without
adrenaline, in controlling haemorrhage form peptic
ulcers. Dramatic success rates of up to 100% have been
claimed. Compared to other methods of endoscopic
haemostasis, injection treatment is simpler and more
economical.
5The work described in this thesis consists of a
series of laboratory and clinical studies on the safety
and efficacy of injection treatment of bleeding ulcers.
Laboratory Studies: The effect of submucosal
injection of several sclerosants (alcohol, ethanolamine,
sodium tetradecyl sulphate) and adrenaline was studied
by injecting them submucosally into the stomachs of
anaesthetised dogs. Repeat endoscopic examinations at
regular intervals showed that the sclerosants
consistently led to. ulceration whereas adrenaline did
not. The ability of submucosal adrenaline to decrease
bleeding from ulcers was then tested in canine bleeding
ulcers created with the Quinton ulcer maker. Submucosal
adrenaline injection caused a significant decrease in
blood loss. The inert carrier substance of adrenaline
had no effect. The effect of adrenaline injection on
gastric mucosal blood flow was studied in rats using
laser Doppler velocimetry and reflectance
spectrophotometry. Adrenaline injection caused a
significant decrease in blood flow due to
vasoconstriction. The inert carrier substance had no
effect. These experiments suggest that adrenaline
injection is non-ulcerogenic and can control bleeding
from ulcers by vasoconstriction.
Clinical Studies: A pilot study was carried out in
637 patients with actively bleeding ulcers. Endoscopic
adrenaline injection controlled the bleeding at the time
of endoscopy in all. Five patients rebled, only 3 out
of the 37 patients required emergency surgery. No
complication was observed. A randomised controlled
trial was then carried out comparing endoscopic
adrenaline injection and conservative treatment. Sixty
eight patients with actively bleeding ulcers were
recruited into the study. Significant decreases in
blood transfusion, emergency surgery and hospital stay
were demonstrated in the injection group. These'studies
indicate that endoscopic adrenaline injection is useful







Upper gastrointestinal haemorrhage is a common cause
for emergency hospital admission. The incidence is
approximately 150 per 100,000 per year and accounts for
5% of all emergency admissions at the Prince of Wales
Hospital, Hong Kong. Peptic ulceration is the commonest
cause of upper gastrointestinal bleeding. Ulcer
bleeding results from the erosion of an artery by the
ulcer. Despite advances in diagnosis and management the
reported mortality of upper gastrointestinal haemorrhage
remains constant at around 10%. Rebleeding or continued
bleeding in hospital increases the mortality 6-12 fold.
The likelihood of developing a rebleed can be predicted
by a large initial bleed and endoscopic stigmata of
recent haemorrhage.
Upper gastrointestinal bleeding is a common medical
emergency and accounts for a considerable proportion of
emergency admissions to hospitals. It was estimated
that in the United States in 1978 there were 114,000
discharges from hospitals with the diagnosis of bleeding
peptic ulcer. The annual incidence per 100,000
population was 53.5. (Cutler Mendeloff, 1981). In
Europe the reported annual admission rates for upper
gastrointestinal haemorrhage ranged from 48 per 100,000
in Scandinavia (Herner et al 1965) to 144 per 100,000 in
North-east Scotland. (Johnson et al 1973).
In Hong Kong the incidence of upper
gastrointestinal bleeding may be even higher. In a one
year period from November 1984 to October 1985 549
such patients were admitted to the Prince of Wales
Hospital. This accounted for 4.8% of all acute
admissions. The estimated catchment population of the
hospital during that time was 350,000. The annual
hospital admission rate for gastrointestinal haemorrhage
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SOURCE OF BLEEDING
The causes of haematernesis and melaena are legion.
Despite minor regional variation in disease patterns,
peptic ulceration is by far the commonest cause of upper
gastrointestinal bleeding. In a world-wide survey of
upper gastrointestinal bleeding, peptic ulceration
accounted for 1,426 (36%) out of 4,010 cases surveyed
(Morgan Clamp 1984). Similarly in a survey on upper
gastrointestinal haemorrhage conducted amongst members
of the American Society of Gastrointestinal Endoscopy,
duodenal ulcer was found in 477 (22.8%) and gastric
ulcers in 459 (21.9%) out of 2225 patients (Silverstein
et al 1981). This is in agreement with the recently
reported endoscopic series of Hunt et al (1983) (49% of
1,316 patients), Cotton et al (1973) (53% of 208
patients), Himal et al (1978) (63% of 334 patients) and
Harris Heap (1982) (49% of 269 patients). The causes
of upper gastro-intestinal haemorrhage for patients
admitted to the Prince of Wales Hospital, Hong Kong,
from September 1984 to November 1985 are shown in Table
1. Peptic ulceration accounted for 74% of patients
presenting with upper gastrointestinal bleeding.
Duodenal ulcers were twice as common as gastric ulcers
in the local population.
Table 1: Causes of upper gastrointestinal bleeding
at the Prince of Wales Hospital,
Hong Kong
(Sept 84- Nov 85)


























Bleeding in a peptic ulcer occurs when the ulcer
erodes into an artery, usually in the submucosal layer.
Erosion of larger arteries on the serosal side, or
occasionally in neighbouring organs, may lead to
torrential haemorrhage. Classical examples are
posterior duodenal ulcers eroding into the gastro-
duodenal artery and lesser curve gastric ulcers eroding
into the left gastric or splenic artery. Such
incidences are fortunately rare. Swain et al (1986)
examined 29 gastric ulcers removed at emergency surgery
for acute bleeding and found that the bleeding artery
measured only 0.66 mm in diameter with a mean internal
diameter of 0.3 mm. Contrary to classical teaching,
atherosclerotic changes were absent in the vessel wall
(Swain et al 1986, Osborn 1954). Thus the increased
death rate in elderly patients cannot be attributed to
atheroma and lack of normal vessel wall contraction;
indeed Northfield (1971) found that young patients were
just as likely to develop a rebleed as elderly patients.
MORTALITY
The mortality rate of upper gastrointestinal
bleeding has remained constant for several decades
despite advances in the diagnosis, monitoring and
treatment. Piper Stiel (1986) summarized results from
12 series from 1900-1940, 25 series from 1940-75 and 20
series from 1975 onwards. Although there is great
variation in the mortality rates ranging from 0-22%, the
overall mortality has remained more or less static at
around 8-10%. The mortality in the American Society of
Gastrointestinal Endoscopy national survey was 10.8%
(Silverstein et al 1981) and that in the Organisation
Mondiale d'Gastro-Enterologie (O.M.G.E.) world-wide
survey was 8.3% (Morgan Clamp 1984). Schiller et al
(1980) studied 2,149 admissions for gastrointestinal
bleeding in Oxford from 1953-67. There was no change in
the mortality rate in three successive five year
periods. Age and sex distribution remained the same
during these periods. The overall mortality was 8.9%.
In comparing mortality rates of various series of
patients with upper gastrointestinal bleeding in the
literature, one must be aware that the patient
populations considered may not be comparable. Besides
the merit of the proposed mode of treatment many factors
can influence the overall mortality rate. Inclusion of
patients with bleeding oesophageal varices will increase
the overall mortality, as varices carry a much worse
prognosis than bleeding ulcers. Likewise, inclusion of
patients who start to bleed in hospital while being
treated for another condition will increase the
mortality rate. Foster et al (1964) found that the
mortality for patients who started to bleed at home was
17.4% while the mortality for those who started to bleed
while in hospital was 51%. Reports that only included
patients who underwent surgery understandably have a
higher mortality. Series that concern only peptic ulcer
disease have the lowest mortality. Endoscopic series
may exclude patients who died before endoscopy could be
arranged or who were deemed unfit for endoscopy.
Perhaps the most important determinant of prognosis in
patient suffering from gastrointestinal bleeding is age.
Kang and Piper (1980) showed that while there was little
change in the overall mortality, there was a marked
reduction in the mortality in those over 60 in the 12
published series in the English literature from 1939-
1977.
PROGNOSTIC FACTORS
Several factors have been shown to influence
mortality in patients with bleeding ulcers. Schiller et
al (1970) found that those aged over 60, haematemesis,
hypotension, anaemia on admission, repeated or continued
bleeding, transfusion requirement of over 10 units, and
gastric rather than duodenal ulcers had a higher
mortality, whereas previous ulcer history and bleeding
episodes in the past had no bearing on the mortality.
Prognosis was better in those whose bleeding was induced
by alcohol or non-steroidal anti-inflammatory agents.
REBLEEDIN6
Continued or recurrent bleeding after admission is
of grave prognostic significance. Further haemorrhage
in hospital has been shown to increase mortality by a
factor of 12 (Avery-Jones 1947), 10 (Needham
McConachie 1950) and 6 (Schiller et al 1970). If the
mortality of upper gastrointestinal bleeding is to be
reduced, effort must be concentrated on this high risk
group.
It is indeed possible clinically to identify the
group of patients who are likely to rebleed. Northfield
(1971), in a retrospective study of 472 patients,
identified a large initial bleed, haematemesis rather
than melaena, varices and chronic gastric ulcers as
factors predisposing to a rebleed. Age, sex or blood
group were not found to be important. Macleod and Mills
(1982) studied 389 patients admitted with upper
gastrointestinal bleeding over a one year period in
Glasgow. They confirmed that further haemorrhage was
predicted by haematemesis, varices and gastric ulcer,
shock and anaemia. They differed from Northfield (1971)
in that they found those over 60 were more likely to
rebleed.
The incidence of recurrent haemorrhage is related
to the time elapsed since the last bleeding episode.
Patients who show no sign of rebleeding for 48 hours are
unlikely to bleed again (Northfield 1971). This has
important implications on how long a patient admitted
with upper gastrointestinal bleeding needs to be
intensively monitored or indeed be kept in hospital.
STIGMATA OF RECENT HAEMORRHAGE
Stigmata of recent haemorrhage (SRH) was first
described by Foster et al in 1978. They considered
fresh bleeding from a lesion, blood clot or slough
adherent to a lesion and a vessel protruding from an
ulcer as evidence that the ulcer had recently bled. In
89 ulcer patients stigmata were identified in 60 (66%).
Of those with stigmata 42% rebled while only 1 in 29
(3%) of those without stigmata rebled (p0.0001). The
presence of SRH was a better indicator of rebleeding
than other factors taken alone or in combination (Foster
et al, 1978)
Griffiths et al (1979) found a "visible vessel" in
28 out of 157 ulcers in 317 consecutive patients
endoscoped for acute upper gastrointestinal bleeding.
Eleven of these were seen to be bleeding at the time of
endoscopy. All 28 patients with visible vessels
continued to bleed or rebled and underwent emergency
surgery. In comparison, only 22% (29129) of ulcers
without visible vessels required emergency surgery.
This was a retrospective study and no comment was made
on how often the ulcer crater could be fully visualised
or whether adherent clots were removed at the time of
endoscopy.
Storey et al (1981) defined a visible vessel as an
elevated red or blue spot that protruded from the ulcer
crater, resistant to washing and often associated with a
red clot. Other stigmata were oozing, adherent clot
or a black spot. In a prospective study of 292 patients
(Storey et al 1981) admitted for acute gastrointestinal
haemorrhage, ulcers were identified in 132 and full
examination of the ulcer base was possible in 117.
Visible vessels were identified in 48%, other stigmata
in 18% and 34% had no stigmata. The incidence of
rebleeding was 56% in those with visible vessels, 8%
with other stigmata and zero in those without any
stigmata. The incidence of rebleeding when any stigmata
were present was 43%. Visible vessels were identified
three times more frequently than in Griffith's study but
only half of those with visible vessels rebled.
Harris and Heap (1982) used the same definitions as
Foster et al (1978). SRH was identified in 52 out of 69
duodenal ulcers and 44 out of 57 gastric ulcers.
Transfusion requirement was higher in those with SRH.
Twenty seven percent of those with SRH underwent
emergency operation whereas none in the group lacking
stigmata underwent surgery.
Wara (1985a) prospectively studied 250 patients
with stigmata of recent haemorrhage. Twenty three
patients with arterial bleeding were excluded. Of the
250 patients studied, 76 were actively oozing 174 had
other stigmata (86 clot, 16 visible vessel only, 62
older stigmata). None of the stigmata emerged as
reliable predictors of rebleeding. However, when a
visible vessel was identified with oozing or clot, a
trend towards major rebleeding was observed.
While all authors agreed that the chance of
rebleeding in an ulcer without SRH is close to zero, the
proportion of patients with SRH that rebled or required
surgery varied in different series. This no doubt
resulted from the different interpretation of what
constituted a visible vessel, or a red or blue spot.
Johnston (1984) suggested that the visible vessel
seen endoscopically is actually a blood clot projecting
from an eroded blood vessel and the term visible
vessel should be changed to invisible vessel with
sentinel clot. Swain et al (1986) made detailed
studies of 18 gastric ulcers with endoscopically
documented visible vessels that subsequently underwent
surgical resection. In 14 cases the 'visible vessel'
actually constituted a clot in an eroded artery that
projected above the ulcer base.
Obviously all bleeding ulcers must, at some point
in time, be actively bleeding. The likelihood of
finding an active bleeding point at the time of
endoscopy is directly related to how soon the endoscopy
is performed rsince the bleeding episode. In the
American Society of Gastrointestinal Endoscopy survey
the incidence of active bleeding identified at the time
of endoscopy was 41.5% if the patient was endoscoped
within 12 hours of admission; this fell to 15% after 48
hours (Silverstein et al 1981). The chance of
rebleeding is related to the time interval since the
last bleed. (Northfield 1973). It is likely that an
actively bleeding vessel, a clot covering the ulcer, a
visible vessel, a red or blue dot and a clean ulcer
without any stigmata represent different stages in the
evolution of a bleeding ulcer.
The use of an endoscopic Doppler device to detect a
patent artery in the ulcer base has been described
(Becky et al 1982). This is clearly a step forward from
visual inspection of the ulcer crater only. Becky and
Casebow (1986) reported that if a Doppler signal is
detected the likelihood of rebleeding and death is
significantly increased. Besides prediction of the risk
of rebleeding, this method has great potential in
endoscopic haemostasis. It allows the identification of
the exact site of the vessel and can be used to
determine if and when the artery has been successfully
sealed by treatment.
CHAPTER 2
MANAGEMENT OF ULCER BLEEDING
SUMMARY
The lowest mortality rates for upper
gastrointestinal haemorrhage are reported from centres
that have a specialised gastrointestinal bleeding team.
The existence of a specialised unit with a defined
policy and the presence of staff experienced in
gastrointestinal haemorrhage contribute to the reduction
in mortality.
The management of gastrointestinal bleeding consists
of l) resuscitation, 2) finding the source of bleeding
and 3) stopping the bleeding.
Fibreoptic endoscopy is the most accurate method of
identifying the bleeding source. Although endoscopy can
identify the source of bleeding in over 90% of cases,
randomised trial comparing endoscopy and barium studies 6
failed to demonstrate a benefit in eventual outcome.
Prior to the advent of endoscopic haemostasis,
surgery was the only practical method of controlling
ulcer bleeding. The indications and timing for
operative intervention remained controversial. A policy
of early surgery for those at risk of rebleeding may
avoid the dangers of rebleeding. This will however lead
to a high operation rate and post-operative mortality in
some patients who may never rebleed.
COMBINED MANAGEMENTS GI BLEEDING TEAM
In most hospitals, patients with haematemesis and
melaena are admitted to medical units. Surgeons are
only called in for consultation when surgical
intervention is deemed necessary. In the face of
general pessimism concerning the constant mortality
trend in upper gastrointestinal bleeding, it is
noteworthy that the lowest mortality rates have been
reported by units that have a specialised interest in
upper gastrointestinal bleeding. Cotton and Russell
(1977) stated that management by a combined
medicosurgical gastrointestinal team is a rarely
ft
achieved ideal. Tanner and Desmond (1950) were the
first to report on the value of a special unit in the
management of upper gastrointestinal bleeding. They
reported a 11% mortality for chronic peptic ulcer from
1941-1950. Hunt et al (1986) showed that the hospital
mortality of bleeding chronic ulcer was 12% from 1960-
1971. This was reduced to 5.8% in the period from 1972-
1982, when a policy of early endoscopic diagnosis,
adequate resuscitation and a policy of early selective
surgery was adopted. Furthermore, within the period of
the prospective study, there was a significant reduction
in mortality from 8% in the first five years to 3.9% for
the second five years, despite an increase in the number
of patients over 60 years of age. There was also a
significant reduction in mortality of those over 60, and
a significant decrease in the number of deaths in
shocked patients. The emergency surgery rate was 34%.
No single factor could be identified as the reason for
the improved results. Hunt suggested that the most
important factor is the application of a defined policy
in a special unit where the staff is experienced in all
aspects of management of patients with bleeding ulcers
(Hunt et al 1983). Himal et al (1978) showed that
mortality from upper gastrointestinal haemorrhage can be
reduced by aggressive management. With a policy of
endoscopy within 12 hours of admission and early surgery
for gastric ulcers and high risk duodenal ulcers, the
mortality was reduced from 12.54% in 1963-1971 to 6.69%
in 1973-1976. The patients were admitted to the surgical
intensive care unit. In Newcastle, Australia, all
patients with acute upper gastro-intestinal bleeding are
admitted to the Gastrointestinal Unit under the joint
management of physicians and surgeons associated with
the unit. A policy of conservative blood transfusion
and early limited surgery was practiced. A mortality of
3.5% was achieved in patients with gastric or duodenal
ulcers. The emergency surgery rate is only 5.1% (Rofe
et al 1985).
Comparing the two Australian series (Hunt 1986,
Rofe et al 1985) the mortality rates were both low (5.8
vs 3.5%), but the emergency surgery rates were very
different (34% vs 5.1%). Both units have a special
interest in upper gastrointestinal bleeding. Patients
were admitted to a special ward where they were closely
monitored. They were managed jointly by physicians and
surgeons experienced in gastrointestinal haemorrhage.
The divergent emergency surgery rates in the two units
suggest that it was the existence of a specialized unit
with a defined policy, rather than the policy itself,
was responsible for the reduction in mortality.
At the Prince of Wales Hospital, Hong Kong, acute
upper gastrointestinal bleeding accounts for 4.8% of
all emergency admissions. In 1985, 549 such patients
were admitted. Management of all patients in the
intensive care unit is clearly impractical. As most
stop bleeding spontaneously and do not require vigorous
resuscitation or surgery, such a policy would represent
a waste of valuable resources. We have adopted a system
whereby all patients with upper gastrointestinal
bleeding are admitted initially to the medical unit.
They are endoscoped within 24 hours. At the time of
emergency endoscopy they are assessed and are classified
as being of either high risk or low risk of further
haemorrhage. This assessment is based on both clinical
and endoscopic criteria. Those who have been shocked
andor possess major stigmata of recent haemorrhage are
seen by both a senior gastroenterologist and a
gastrointestinal surgeon and then transferred to the
surgical gastroenterology ward where they are
intensively monitored. Central venous pressure and
hourly urine output are monitored in those over 60 years
of age and those who are in shock. In 1985, of the 549
patients admitted with upper gastrointestinal bleeding
105 (19%) were transferred to the surgical ward. Forty
four (8%) underwent emergency surgery. The overall
mortality was 6%. Four hundred and three patients were
bleeding from peptic ulcers, 36 (8.6%) underwent
emergency surgery with 5 post-operative deaths, giving
an operative mortality of 14%. The overall mortality
for bleeding peptic ulcers was 3,. 7%. Of those who were
returned to the medical ward after endoscopy, only one
patient developed a major rebleed that required
emergency surgery. This policy of selective intensive
monitoring optimized the care of these patients.
Haemorrhage from peptic ulcers stops spontaneously
in approximately 80% of cases, about 20% continue to
bleed or rebleed. The mortality of the latter group is
much higher. Logical management of a bleeding episode
consists of 1) assessment and resuscitation 2)
identification of the source of haemorrhage and if
necessary 3) stopping the bleeding.
RESUSCITATION
Replenishing the blood volume is the mainstay of
resuscitation in patients that have lost a significant
amount of blood. There is no controlled randomised study
to show that blood transfusion has any effect on
decreasing the mortality of upper gastrointestinal
bleeding. However, to deny transfusion to a patient in
oligaemic shock defeats the logic of medicine and
physiology (Piper and Stiel 1986). Doubt has- however
been cast on this time honoured principle by Blair et al
(1986) who suggested that transfusion of stored blood
reverses the hypercoagability associated with blood loss
and increases the chance of further haemorrhage.
With the increasing age of the population the
elderly constitutes a large proportion of the patients
admitted with upper gastrointestinal bleeding. The
proportion of patients aged over 60 in British series of
acute upper gastrointestinal haemorrhage increased from
under 10% in the 1900's to 50% in the 1970's (Logan
Finlayson 1976). Pre-existing medical problems
concerning cardiac, respiratory and renal systems are
likely to complicate upper gastrointestinal bleeding in
these elderly patients. Such patients not only
withstand acute blood loss poorly, inappropriate rapid
volume expansion is also hazardous. Central venous
pressure monitoring may be particularly valuable in
these patients. Andersen (1970) has found this
technique of value in detecting episodes of major
haemorrhage in addition to guiding the rate of
transfusion.
IDENTIFICATION OF THE SOURCE OF BLEEDING
HISTORY EXAMINATION
The clinical history and physical examination,
although important, are poor guides to the exact origin
of haemorrhage. Ulcer bleeding is the commonest cause
of upper gastrointestinal haemorrhage, but 25% of
patients with chronic dyspepsia are not bleeding from
ulcers (Cotton and Russell 1977). On the other hand 30%
of patients who are bleeding from ulcers deny previous
dyspepsia (Cotton Russell 1977). Recent salicylate
intake suggests acute gastric erosions, although non¬
steroidal anti-inflammatory drugs can also provoke
bleeding from chronic ulcers.
It is particularly important to diagnose bleeding
from varices. Variceal bleeding is less likely to stop
spontaneously, the prognosis is worse and the treatment
is different from that of ulcer bleeding. Here again
the history may be misleading, as known cirrhotics and
even patients with known oesophageal varices may be
bleeding from another source. McCray et al (1969)
endoscoped 27 patients with varices during a bleed.
Only 5 of them were bleeding from varices. The other
causes of bleeding were gastric erosions 16 and ulcers
4. The cause remained unknown in the other two. To
avoid unnecessary and hazardous therapeutic manoeuvres
such as balloon tamponade or inappropriate surgery,
precise diagnosis is essential. McCray et al (1969)
concluded that this may only be achieved by prompt
endoscopy.
ENDOSCOPY
More than 90% of patients presenting with
haematemesis or melaena have a bleeding lesion proximal
to the ampulla of Vater. With the development of
longer, more flexible fibre-optic endoscopes which allow
retroversion of the tip, the oesophagus, stomach,
duodenal bulb and the second and third parts of the
duodenum can be visualized. In experienced hands the
bleeding lesion can be identified confidently in over
90% of patients endoscoped within 24 hours of admission
(Cotton et al 1973, Katon Smith 1973). The earlier
the endoscopy is performed, the greater the diagnostic
yield. (Forrest et al 1974, Leinicke 1976).
Several series (Stevenson et al 1976, Cotton et al
1973, Katon Smith 1973) have shown that emergency
endoscopy is more accurate than barium examination in
identifying the source of bleeding. This is hardly
surprising as 15% of patients have multiple lesions and;
26% of patients with duodenal ulcers are bleeding from
another source (Cotton et al 1973). A sizable
proportion may be bleeding from mucosal lesions, which
are unlikely to be demonstrable by radiology even with
the double contrast technique.
While the superior diagnostic yield of endoscopy is
not in doubt, emergency endoscopy has not been shown to
improve the mortality in patients with upper
gastrointestinal bleeding. Randomised trials comparing
endoscopy and barium meal (Morris et al 1975, Dronfield
et al 1982), while confirming the diagnostic superiority
of endoscopy, failed to demonstrate a benefit in
eventual outcome. Peterson et al (1981) randomised
patients in whom the bleeding had already stopped to
emergency endoscopy or no endoscopy. Patients in the
'no endoscopy' group were only endoscoped when they
rebled. No difference in patient outcome was
demonstrated.
This apparent anomaly reflects the inability of the
clinician to capitalize on the more accurate information
gained at endoscopy. A diagnostic tool is unlikely to
alter the outcome unless the findings can influence
the management. In this area endoscopic prediction of
further haemorrhage and methods of endoscopic
haemostasis are promising areas which have been
intensively researched in the past few years.
ANGIOGRAPHY
In rare instances the source of bleeding may remain
obscure after a thorough endoscopic examination of the
upper gastrointestinal tract. Mesenteric angiography
during the active phase of haemorrhage can demonstrate
extravasation of contrast medium into the
gastrointestinal lumen. Extravasation can be
demonstrated when the bleeding is as little as
0.5 mlmin. (Nusbaum Baum 1963). This technique is
only useful when there is active bleeding. The main
indication for using angiography is bleeding of obscure
origin, e.g. small bowel or colonic bleeding. i
STOPPING THE BLEEDING
LAVAGE
Wangensteen et al (1958, 1959) have demonstrated
that gastric hypothermia to 10°C decreases gastric blood
flow, gastric secretion and the quantity of digestive
enzymes in the gastric juice. Irrigation of the stomach
with iced saline has been common practice in the
management of patients with gastrointestinal bleeding
although there has been no controlled studies to confirm
its efficacy. The deleterious effects of gastric
cooling on the blood clotting mechanisms has been
pointed out by Waterman and Walker (1973). Cold saline
lavage in dogs decreased gastric blood flow by 50%, but
bleeding time was increased three fold, clotting time
increased by 60% and prothrombin time 100%.
The addition of noradrenaline, a potent
vasoconstrictor, to the lavage fluid has been reported
in an uncontrolled series (Kiselow and Wagner 1973).
This was successful in stopping the bleeding on 7 of 13
occasions. Noradrenaline is cleared from the
circulation rapidly by the liver, so its instillation
into the stomach, even in large quantities, does not
lead to systemic complications (LeVeen et al 1972).
This method is particularly attractive in stopping
haemorrhage from diffuse haemorrhagic gastritis. The
control of gastric mucosal blood flow, however, lies in
the submucosal plexus rather than the mucosa.
Mucosally applied agents have to diffuse through the
mucosa to exert their effect. Guth and Smith (1974)
have demonstrated by in vivo microscopy that application
of adrenaline on the mucosal aspect needs to be more
than 150 times more concentrated to produce the same
effect than if the drug is administered submucosal ly.
There is no good evidence to indicate that lavage in any
form can influence the outcome of a major bleed from
ulcers.
DRUGS
Agents which have been investigated in this context
include H2 blockers, antifibrinolytics and somatostatin.
H2 blockers: These compounds effectively decrease
acid and pepsin secretion and consistently heal gastric
and duodenal ulcers. Their use in acute ulcer bleeding
is logical. However, randomised clinical trials have
failed to demonstrate any influence in mortality
(Langman 1985). Most, if not all, of the reported
trials on H2 blockers are too small to demonstrate the
effect of treatment. (Collins Langman 1985). The
mortality rate of upper gastrointestinal bleeding is
only 10%, so an unreasonably large number of patients
would need to be recruited to demonstrate a moderate,
but useful reduction in mortality. Collins and Langman
(1985) estimated that 10,000 patients would need to be
randomised to demonstrate a 20% improvement of
mortality. Subgroup analyses in trials where overall
results show no significant difference may not be
statistically sound and have led to claims that gastric
but not duodenal ulcers may be benefited (Hoare et al
1979) and vice versa (Dawson Cockel 1982). Collins
and Langman (1985) collected data from all 27 randomised
trials of H2 blockers in acute upper gastrointestinal
haemorrhage. Analysis of the combined data of over
2,500 patients suggests that H2 blocker treatment may
reduce the rates of rebleeding, surgery and death by 10,
20, and 30% respectively.
Transexamic acid: This antifibrinolytic agent has
been assessed in at least 4 randomised studies.
Significant lowering of transfusion and emergency
surgery rates were demonstrated by Cormack et al (1973),
Engqvist et al (1979) and Biggs et al (1976). The study
in Nottingham (Barer et al 1983) was the only one where
a significant reduction of mortality was shown.
Inexplicably, there was no difference in the rebleeding
or operation rates in this study.
Somatostatin: Somatostatin, a peptide hormone which
inhibits gastric secretion, stimulates gastric mucus
production and decreases splanchnic blood flow, has been
shown to be of benefit in two small controlled trials
(Coraggio et al 1984, Kayasseh et al 1978). The drug is
expensive and needs to be given by continuous infusion
because of its short half-life. Another trial involving
95 patients from Scandinavia showed a reduction in the
emergency operation rate (Magnusson et al 1985).
However a much larger trial in which 630 patients were
randomly allocated to somatostatin or placebo infusion
demonstrated no significant benefit in rebleeding,
operation rate or mortality (Somerville et al 1985).
Other compounds: Several new compounds e.g.
omerprazole, a more potent inhibitor of gastric acid
than H2 blockers, prostaglandin analogs such as
misoprostol, and mucosal protective agents such as
sucralfate have been shown to be useful in the treatment
of peptic ulcer disease. The place of these agents in
the treatment of bleeding ulcers has not been adequately
assessed. v
INTERVENTIONAL RADIOLOGY
The use of mesenteric angiography in identifying
obscure bleeding sources has been discussed. Extension
of diagnostic mesenteric angiography to control bleeding
includes the intra-arterial infusion of vasoactive
substances (e.g. vasopressin) or the selective
embolisation of branches of mesenteric vessels.
Moderate success has been reported with these methods.
The mortality in radiological series is high, as many of
the patients referred for interventional radiology are
not fit for surgery or surgery has failed to control the
bleeding. Vasopressin controls the bleeding only in a
minority of patients, in only a quarter is the control
long term (Johnson Widrich, 1976). Embolisation seems
to be more successful. Reuter (1979) reported on 40
successful procedures, but no controlled trial of this
method has yet been reported. Serious complications
such as the infarction of the duodenum, spleen and
intestines may result. (Shapiro et al, 1981). At
present the use of selective embolisation should be
limited to patients who have serious contraindications
to surgery.
SURGERY
Prior to the introduction of endoscopic means of
controlling ulcer bleeding the only effective means of
stopping ulcer bleeding had been surgery. Mikulicz
performed the first recorded operation for haematemesis
in 1887 (Tanner Desmond 1950). Surgery had, however,
been used as a last resort when all else had failed
until an aggressive surgical approach was advocated by
Gordon-Taylor of London and Finsterer of Vienna. These
pioneer gastric surgeons recognized the dangers of delay
and recommended early operation for bleeding chronic
ulcers to prevent the dangerous rebleed (Gordon-Taylor
1935). Finsterer (1939) chose to operate within the
first 48 hours of admission if the diagnosis of a
chronic ulcer was fairly certain, before another
haemorrhage weakened his patient. Local anaesthesia was
used. In 78 patients that underwent early surgery (71
partial gastrectomies and 7 gastroenterostomies) there
were 4 deaths, a operative mortality of 5.1%. In 49
patients who were operated on late, his mortality was
36% (Finsterer 1939). The foundations of modern
surgical management of bleeding peptic ulcers were laid
by Norman Tanner, who at St. James' Hospital, Balham,
accumulated a vast personal experience of surgical
treatment of this condition. From 1940 to 1967, 3,579
admissions due to bleeding from the upper
gastrointestinal tract were reported by Tanner and his
associates. (Tanner, 1964)
The timing of surgery: Sir Gordon Gordon-Taylor
stated in 1935: It may be long before physician and
surgeon see absolutely eye to eye as to the necessity or
the appropriate moment for operative interference.
Today the relationship between gastroenterologists and
gastrointestinal surgeons is less acrimonious; indeed
the lowest mortality in bleeding ulcers is reported from
combined gastrointestinal units where patients are cared
for jointly by physicians and surgeons (Hunt 1984, Rofe
et al 1985). The indications and timing for operative
intervention in bleeding ulcers remained controversial.
Approximately 80% of patients admitted for upper
gastrointestinal haemorrhage stop bleeding spontaneously
(Clason 1986), the problem lies in selecting the 20%
that do not. The proponents of early surgery hoped that
by the early removal of the bleeding point a subsequent
fatal rebleed may be avoided. However an aggressive
surgical approach will inevitably lead to a high
operation rate. Surgery will be performed on patients
who may not rebleed, some of whom will die as a direct
result of post-operative complications.
Tanner (1964) defined severe or massive haemorrhage
as the presence of shock on admission with a systolic
blood pressure of below 100 mm Hg. He suggested that
these patients should be operated on once they have been
resuscitated. This dictum has been widely accepted over
the years (Read et al 1965, Thorne Nyhus 1965).
Patients under 50 years of age have a very low mortality
(Cocks et al 1972) and most surgeons would adopt a more
conservative policy, setting transfusion limits and
operate only if there were signs of recurrent
haemorrhage (Hunt 1986).
Several groups have shown that the adoption of an
aggressive management policy can improve the mortality
°f upper gastrointestinal bleeding. Hellers and Ihre
(1975) adopted a policy of early investigation by
endoscopy, an aggressive surgical policy and intensive
care. The operation rate rose from 11% to 25%,
transfusion requirement fell from 17 to 7 units,
operative mortality fell from 47 to11% and mortality in
unoperated patients fell from 17% to 8%. Hunt et al
(1979, 1986) in Melbourne, Australia, admitted all
patients with gastrointestinal bleeding to a specialized
unit with a policy of early endoscopy, adequate
resuscitation and early selective surgery. Mortality
for bleeding ulcers was 12% before thisvpolicy was
adopted, this was reduced to 5.8% afterwards. The
emergency surgery rate was 34%. The improvements in the
results in these series are impressive, but the
identification of any single factor is impossible.
Another group in Australia also admitted all patients to
a single gastrointestinal unit where they were jointly
managed by physicians and surgeons (Rofe et al 1985).
Although the emergency operation rate was much lower
than in Hunt's unit (5.1% vs 34%) the mortality for
bleeding ulcers was equally impressive (3.5%.). It is
likely that the existence of a specialized unit and the
availability of experienced clinicians interested in the
disease is more important than the exact indications for
surgery in achieving excellent results.
Dronfield et al (1979) compared the results of two
hospitals in Nottingham which have different policies
for emergency operation for bleeding ulcers. The
patients were drawn from a common source and were
comparable in severity of bleeding. Hospital A operated
on 32%, Hospital B had a more aggressive policy and
operated on 48%. The post-operative mortality rates
were 20% in both hospitals. The overall mortality was
higher in hospital B (9% vs 6%). Two thirds of the
Post-operative deaths were due to cardio-respiratory
causes. Another study from Nottingham found that
although the operation rate had fallen from. 1 in 3 in
1975-1977 to 1 in 5 in 1978-1980 there had been no
appreciable effect on mortality (Vellacot et al 1982).
Almost all the deaths in the medically managed group and
three quarters of the deaths in the surgical group were
over 65 years of age. These studies cast serious doubt
that an aggressive surgical policy can improve mortality
in an aging population.
The only prospective randomised study to compare
early and delayed surgery in bleeding ulcers was carried
out in Birmingham. Morris et al (1984) allocated 142
patients to either early or delayed surgery. Criteria
for early surgery were: 4 units of blood or plasma
expander required to correct acute blood loss in 24
hours, one rebleed, endoscopic stigmata (active
bleeding, visible vessel, adherent clot or spots), one
previous bleed with two years of dyspepsia. Criteria
for surgery in the delayed group were: 8 units of blood
or plasma expander in 24 hours, two rebleeds, persistent
bleeding requiring 12 units in 48 hours or 16 units in
72 hours. In those under 60 there was no death in
either group but the early surgery policy led to an
unacceptably high operation rate (47% vs 6%) and this
part of the trial was terminated. In those over 60, the
operation rate was 62% in the early group and 27% in the
delayed group. The leading indication for early surgery
being the presence of endoscopic stigmata. There were 3
deaths in 48 patients (6%) allocated to the early group
and 7 deaths in 52 patients (13%) allocated to the
delayed group. Analyzed on the intention .to treat basis
the difference was not statistically significant, either
overall or when gastric and duodenal ulcers were
analyzed separately. One patient allocated to the early
group did not get operated on until criteria for delayed
surgery were satisfied and died. When the results were
analyzed on a treatment received basis, a significant
difference was found in the subgroup of patients with
gastric ulcers over 60 years of age. Seven out of the 8
patients who died in the delayed group died from either
exsanguination or the effects of blood loss and massive
transfusion. The authors concluded that for patients
over 60 an aggressive policy reduces mortality.
It is now established that the risk of further
haemorrhage can be predicted to some extent by the
severity of the initial bleed and the presence or
absence of endoscopic stigmata of recent haemorrhage.
Hypovolaemic shock has long been accepted as the best
indicator of a severe bleed and has been advocated as a
strong indication for surgery. The presence of active
bleeding, visible vessel, or an adherent clot on
endoscopy also increase the likelihood of rebleeding.
The proportion of patients with endoscopic stigmata that
rebled vary widely from one series to another. In a
prospective analysis of 177 patients with bleeding
ulcers, Bornman et al (1985) found that shock predicted
rebleeding in 48%. The predictive value• of a clot in
the ulcer base and a visible vessel was 23% and 50%
respectively. They considered that these were not high
enough to justify a change from a conservative approach
to early operation. However when shock on admission
were taken in combination with important signs of recent
haemorrhage (visible vessel or clot) the predictive
value was as high as 79%. The authors suggested that
intervention is warranted in this group to reduce the
risk of a second haemorrhage. Whether a policy based on
such selection can reduce mortality must await further
randomised trials.
Choice of operation: There is no general agreement
as to the ideal operation for ulcer bleeding. For
duodenal ulcers the early surgeons used Polya
gastrectomy. Tanner (1964) advocated gastrectomy as the
best safeguard against rebleeding. This was associated
with an operative mortality of almost one third in some
centers, the chief cause of which was duodenal blow out
(Foster et al 1964, Jones et al 1973). Smith Farris
(1958) described the use of vagotomy, pyloroplasty and
underrunning of the bleeding point for bleeding duodenal
ulcers. They reported 21 patients treated this way with
no death, no postoperative bleeding and no ulcer
recurrence. Carruthers in Leeds studied 117 patients
operated on for bleeding ulcers. The mortality of
gastrectomy was 18% while that of vagotomy and
pyloroplasty was 7%. Five out of 48 patients treated by
vagotomy rebled, three of whom needed gastrectomy
(Carruthers et al 1967).
Vagotomy, pyloroplasty and underrunning of the
bleeding point has become increasingly popular as the
operation of choice for bleeding duodenal ulcer (Grime
1979). The main criticism of this operation is the
hazards of early recurrent bleeding, which range from 7-
36% in published series. This is more likely in large
posterior ulcers, which unfortunately also make for a
very difficult duodenal stump closure if Polya
gastrectomy is employed.
Highly selective vagotomy has been used in treating
bleeding ulcers. The bleeding point may be reached by a
gastrostomy, duodenotomy or a gastroduodenostomy.
Johnston (1977) has shown that the pylorus can be
divided and repaired with no deleterious effect. Highly
selective vagotomy is likely to be too tedious in a
patient with severe bleeding unless the surgeon has
extensive experience with this operation.
In bleeding gastric ulcers the standard operation
is a Billroth I gastrectomy (Hunt 1986). Vagotomy and
pyloroplasty with oversew or excision of the ulcer has
also been used, especially in poor risk patients and in
high lesser curve ulcers. In addition to the problems of
early rebleeding, there is also the danger of missing an
unsuspected carcinoma. An incidence of 12% has been




The development of endoscopic means of stopping
ulcer bleeding and preventing rebleeding without resort
to surgery represents a major advance in the treatment
of upper gastro-intestinal haemorrhage. The many
methods that have been tried may be conveniently
classified into thermal and non-thermal methods.
Several modalities have now been shown to be effective,
but the ideal method has not yet been identified. Laser
is expensive, difficult to use and not portable. It is
therefore unlikely to gain popularity as simpler,
cheaper and perhaps more effective methods, such as
BICAP, heater probe or injection are available.
INTRODUCTION
The introduction of the fibreoptic endoscope has
revolutionized the practice of gastroenterology.
Lesions in the whole of the gastrointestinal tract can
now be visualized endoscopically and in most cases
biopsies can be taken to confirm the diagnosis. With
increasing expertise and dexterity on the part of the
endoscopist, and ingenuity on the part of the instrument
makers endoscopy has progressed from a purely diagnostic
to a therapeutic tool. Diseases that used to be treated
by surgery can now be treated through the endoscope.
Notable examples are endoscopic papillotomy for common
duct stones (Cotton et al 1981) and colonoscopic
polypectomy (Williams et al 1973).
In patients with acute upper gastrointestinal
haemorrhage emergency endoscopy within the first 12-24
hours of admission has proved to be extremely valuable
in identifying the bleeding point (Cotton et al 1973).
Until recently surgery has been the only effective means
°f controlling haemorrhage from bleeding ulcers.
Rebleed in hospital is associated with a 6-12 fold
increase in mortality and it has long been recognized
that in those patients requiring surgery it is better
done early than late (Finsterer 1939). However only
20-30% of all patients will rebleed. Although patients
with a high risk of rebleeding may be identified by
using clinical and endoscopic criteria, this selection
is not 100% accurate. A policy of operating before
rebleeding occurs will inevitably lead to unnecessary
operations in a certain percentage and post-operative
mortality and mortality in those who might not have bled
again. A non-operative means of controlling the
haemorrhage, without the risks of anaesthesia and
laparotomy, is clearly very attractive.
The bleeding point can be clearly visualized in
over 90% of cases at emergency endoscopy. Active
bleeding is also commonly seen at endoscopy. A direct
attack on the bleeding point through the fibreoptic
endoscope is therefore conceptually very appealing.
Injection sclerotherapy for bleeding oesophageal
varices, initially through the rigid endoscope and more
recently through the flexible endoscope, is the first
application of this concept to control gastrointestinal
haemorrhage. In the past decade there have been
numerous reports of methods of controlling non-variceal
bleeding endoscopically (Macdougall et al 1982, Yassin
and Sherif 1983, Joffe 1984).
Endoscopic means of haemostasis may be classified
into non-thermal and thermal methods (Table 2). Non-
thermal methods that have been tried include the topical
application of clotting factors, tissue glue, arterial
clips, and local injection of various agents. Thermal
methods include laser photocoagulation, heater probe and
electro-coagulation.




















Linscheer and Fazio (1979) described a four channel
tube to deliver clotting factors to a bleeding ulcer.
Saline is used to wash the lesion, C02 to dry it, and
fibrin and thrombin is sprayed onto the bleeding area.
They tested the device in experimental ulcers in
heparinised and unheparinised dogs and demonstrated a
significant reduction in bleeding time. However Jensen
et al (1980) using the same instruments and experimental
model, were unable to demonstrate any beneficial effect.
This method has the advantage of using a physiological
mechanism to stop bleeding and does not induce any
tissue necrosis. It is unlikely to be effective in
controlling major haemorrhage, especially from a
spurting artery.
COLLAGEN
Microcrystalline form of bovine dermal collagen
stops bleeding by activation of the intrinsic clotting
mechanism and by swelling of the collagen. It has shown
some promise in stopping bleeding from standard ulcers
(Klein et al 1980). There are no reports of its use in
humans.
TISSUE GLUE
Cyanoacrylate plastic tissue adhesives exhibit
strong bonding to mammalian tissues and were developed
in the 1950s for use in battlefield trauma.
Trifluoroisopropyl 2-cyanoacrylate (Flucrylate, MBR4197)
aerosolizes easily and polymerizes in less than 10
seconds. It can be delivered to the bleeding ulcer in
aerosol form by a jet of C02 and freon. Martin and
Silvis (1977) found tissue glue effective in stopping
chronic ulcer bleeding in dogs. The same group of
workers also found apparent clinical effect in an
uncontrolled series of 12 critically ill patients.
Portell et al (1978b) studied Flucrylate in standard
experimental ulcers and found it ineffective in stopping
active bleeding. The glue only capped the surface,
while continued bleeding occurred with dissection of
blood along the path of least- resistance. A multi-
center controlled trial of this technique demonstrated
no significant benefit and has been discontinued (Silvis
1981).
ELECTROMAGNETIC TAMPONADE
In this method fine iron particles are suspended in
a mixture of thrombin, glycerol, water and
carboxylmethylcellulose which is pulled against the
bleeding lesion by an electromagnet. (Smith et al 1980).
It may be effective in diffuse lesions but is unlikely
to be effective in brisk bleeding (Carlson et al 1980).
ARTERIAL CLIPS
Haemostatic clips which can be applied with the
endoscope are now marketed by Olympus (Hajiro et al
1986). The technique is cumbersome, clip application is




Among the methods used for endoscopic haemostasis,
laser (light amplification by stimulated emission of
radiation) has attracted the most attention in both the
medical literature and the lay press. The method
involves directing the high energy laser light through
a flexible quartz fibre lead that has been passed
through the biopsy channel of the endoscope, at the
bleeding point. The light energy is absorbed by the
target tissue and changed into heat which coagulates the
bleeding vessel.
Two types of lasers have been used for endoscopic
haemostasis. The argon laser emits light in the blue
green spectrum. The neodymium-Yytrium Aluminum Garnet
(Nd-YAG) laser emits invisible light in the infra-red
range. The Nd-YAG laser is the more penetrating.
Laboratory studies have been carried out by several
groups (Silverstein et al 1975, Silverstein et al 1979,
Dixon et al 1979, Brown et al 1979) using standard
bleeding ulcers created in heparinised dogs. Both
lasers are effective in controlling haemorrhage. The
correct power setting and pulse duration have also been
established in these animal experiments. The Nd-YAG
laser is the more powerful and can coagulate vessels of
up to 3mm in diameter.
Clinical application followed and many reports of
the successful use of both types of lasers appeared. In
a world-wide survey the argon laser was successful in
70-100% of patients and the Nd-YAG laser in 84% of
patients (Dwyer 1981).
Several controlled trials of laser treatment have
been reported with contradictory results. Three trials
with the Argon laser have been reported. In a trial of
16 patients with spurting arterial haemorrhage, Jensen
et al (1982) demonstrated a decrease in the rebleeding
rate in the treatment group. Swain et al (1981) also
demonstrated a benefit with laser treatment in spurters
and patients with visible vessels. No difference in
oozing ulcers and ulcers with minor stigmata was
demonstrated. Vallon et al (1981), however, failed to
demonstrate any significant benefit in any of the
subgroups. When the results of these three trials were
pooled, significant reductions in rebleeding, urgent
surgery and deaths were apparent in patients with active
bleeding or non-bleeding visible vessels. No benefit
could be identified in patients with other stigmata
(Machicado 1987).
With the YAG laser, two trials which included
patients with major bleeds and active bleeding at the
time of endoscopy but without precise definition of the
bleeding point failed to show a positive effect (Ihre et
al 1981, Escourrou et al 1981). A trial from Belgium
demonstrated a significant reduction in rebleeding, but
only in the group with active bleeding (Rutgeerts 1982).
Swain et al (1983) randomised only ulcers with SRH that
were accessible to laser therapy and demonstrated a
significant reduction in rebleeding, both in the whole
trial and in those with visible vessels alone. MacLeod
et al (1983) included patients with major blood loss
with ulcers bearing stigmata of recent haemorrhage.
Significant reduction of rebleeding and surgery was
demonstrated in those with visible vessels. Krejs et al
(1987) did not show any benefit for laser treatment as a
whole or in subgroups with active bleeding, non-bleeding
visible vessels, or other SRH. In this trial 61% of
patients have minor SRH that carry little risk of
rebleeding, and severe bleeding that required emergency
surgery was induced by laser treatment in several non-
bleeding ulcers.
Many authors (Vallon et al 1981, MacLeod et al
1983) have stressed the technical difficulty of laser
photocoagulation, especially in obtaining adequate
endoscopic access to permit an en face view of the ulcer
in the duodenum. Severe bleeding may also be
precipitated if a thrombosed vessel is evaporated by the
laser. Laser,, photocoagulation requires a high degree of
endoscopic expertise and the results are obviously
operator dependent. In addition to operator
differences, the inclusion of different patient
populations (inaccessible ulcers and ulcers with low
risk of rebleeding) may have accounted for the
discrepancy in the results of the published trials.
ELECTROCOAGULATION
The use of cautery to stop gastrointestinal
bleeding dates back to antiquity when red hot irons were
used to treat bleeding from haemorrhoids. Heat can be
generated at tissue interfaces by rapidly alternating
currents. Electrocoagulation by diathermy is now an
indispensable adjunct in all branches of surgery.
Several types of electrocoagulation electrodes have been
designed to be used through the fibreoptic endoscope.
They have an important advantage over the non-contact
methods in that pressure can be applied to the bleeding
vessel prior to coagulation. A stronger seal can thus
be achieved. Most electrodes have a built-in wash
channel which allow the target area to be washed clean
of blood so that the bleeding point can be accurately
identified and coagulated. The probe can be applied to
the lesion at any angle and many of the problems of
access associated with laser is avoided. Other
advantages are low cost (approximate cost HK$ 100,000),
portability and safety for the staff without any need
for optical protection.
Currently available electrocoagulation methods are
monopolar electrocoagulation, liquid monopolar
electrocoagulation and bipolar electrocoagulation.
Monopolar electro-coagulation: In this method
current flows through the body of the patient and exits
via a ground plate. This method is widely used for
endoscopic papillotomy and polypectomy. In a series of
86 patients with active bleeding, Papp (1982)
successfully coagulated 78. Amongst these 78 patients,
10 rebled. Of those who rebled, 5 underwent emergency
surgery, 4 had successful recoagulation and 1 died
before surgery. Other workers have reported a similarly
high success rate of 81% in 69 patients (Wara et al
1980). Papp (1982) also reported a randomised
controlled trial of the use of monopolar coagulation in
patients with non-bleeding visible vessels. Thirteen of
16 patients in the control group had recurrent
haemorrhage, only 1 out of 16 coagulated patients
developed rebleeding.
The depth of injury with monopolar
electrocoagulation is not as predictable as with other
probe techniques. Transmural tissue damage is more
common with the monopolar probe than the bipolar probe
or the heater probe (Swain et al 1984). Perforations
have indeed been reported in some clinical series (Papp
1982, Koch et al 1972). Another problem is that the
monopolar probe often sticks to the coagulated tissue.
Removal of the probe may restart the bleeding. Char may
also develop on the probe after multiple applications.
Char increases electrical impedance and makes
coagulation less effective.
Liquid monopolar probe: Also known as the electro-
hydro-thermal probe, this device uses a thin, flowing
film of water at the tip of the electrode to reduce
sticking (Matek et al 1979, Swain et al 1984). Wara
(1985b) applied this technique to 77 patients with major
bleeding from peptic ulcers assessed as requiring
emergency surgery. The technique failed to control
haemorrhage in 14 (18%). Endoscopic haemostasis was
obtained in 63 patients but haemorrhage recurred in 18
(29%), 11 of whom required surgery. Freitas et al
(1985) conducted a randomised controlled trial of liquid
monopolar electrocoagulation. Seventy three patients
were entered into the study, 21 were actively bleeding,
57 had other stigmata of recent haemorrhage. There were
no complications associated with electrocoagulation.
The group with active bleeding was too small for any
difference to be detected. In patients with visible
vessels but no active bleeding, rebleeding was reduded
from 53% (917 patients) to 21% (314 patients; p0.05).
Emergency surgery was reduced from 47% (817 patients)
to 14% (214 patients; p0.05).
Bipolar electrocoagulation: In this method the
electrical current flows between electrodes on the probe
and has a limited current pathway. Problems with earth
plates and aberrant current paths are avoided. The
depth of injury is more predictable and the incidence of
transmural thermal injury much lower (Swain et al 1984):
The commercially available BICAP probe has six
electrodes with alternating polarities arranged in a
circumferential array. Electrical contact is
established when any part of the circumference of the
probe touches the target tissue. Two different probe
sizes are available. The larger probe (3.2 mm) has been
found to be more effective in controlling canine
arterial haemorrhage (Morris et al 1985), but requires a
therapeutic endoscope with a large biopsy channel for
its use.
Two small randomised trials of the small BICAP probe
have shown no benefit (Kernohan et al 1984, Goudie et al
1984). O'Brien et al (1986), in a trial of the smaller
probe in 204 patients, were able to demonstrate a
decrease in the rebleeding rate. Rebleeding and
mortality rates were higher early in the tria,
suggesting the need for experience in the application of
the probe. In Los Angeles, Laine (1987) conducted a
randomised trial using the larger probe in 41 patients
with active bleeding. Haemostasis was achieved in 90% of
the electrocoagulation group, transfusion was reduced
from 5.4 units to 2.4 units, hospital stay was reduced
from 7.2 days to 4.4 days and the percentage needing
emergency surgery was reduced from 57% to 14%. These
differences were statistically different. The
mortality, although lower in the electrocoagulation
group, was not significantly different.
The BICAP probe was compared to YAG laser in a
randomised trial of patients with active bleeding or
non-bleeding visible vessels. All patients had
adrenaline injection prior to coagulation. The two
methods were equally effective and the need for
emergency surgery and mortality rates were similar
(Rutgeerts et al 1987).
THE HEATER PROBE
This device (Portell et al 1978a) consists of a
metal tip heated by a computer controlled coil which
heats up the tip to 250°C. A pre-determined energy
pulse (10-30J) is delivered by pressing a foot switch.
The tip is covered with a non-stick coating to minimize
sticking. A proximally situated wash channel allow
vigorous washing of the bleeding point to clear away
blood clots. As in the BICAP device, pressure can be
maintained on the bleeding vessel during coagulation, so
that coaptive coagulation results. A disadvantage of
the method is that delivery of 30J of energy requires up
to 8 seconds, during which time the probe has to be
maintained in contact with the bleeding point.
Early experience with the heater probe is
encouraging. Using a prototype probe with inferior
washing characteristics, Shorvon et al (1985) were able
to coagulate 12 out of 16 ulcers. Four duodenal ulcers
could not be coagulated because of clots or active
bleeding. Only one of the 12 successfully treated
ulcers rebled. As yet no controlled vtrial of this
device has been reported, but retrospective comparisons
showed that the heater probe is superior to the YAG
laser (Johnston et al 1985) and as effective as the
BICAP probe (Jensen et al 1986).
MICROWAVE COAGULATION
This novel method utilizes the principle that
water-rich tissues absorb microwave energy and transform
it into.heat which causes coagulation. This method was
first designed to be used in liver surgery to decrease
blood loss (Tabuse et al 1985a). The microwave energy
can be directed to the tissues through a 2.7mm diameter
co-axial cable, which can be passed through the biopsy
channel of an endoscope. The terminal portion of the
cable ends in a needle like electrode which projects for
2-3mm. The bleeding lesion is penetrated by the
electrode prior to coagulation. Vessels of up to 3mm in
diameter can be coagulated. Tabuse et al (1985b) used
this method 24 times in 19 patients with various lesions
in the upper gastrointestinal' tract. Bleeding was
controlled for 24 hours in 84%, and for 72 hours in 79%.
There was one perforation.
CHAPTER 4
INJECTION THERAPY FOR ULCER BLEEDING
SUMMARY
In' recent years the use of local injection of
various sclerosants with or without adrenaline to
control non-variceal upper gastrointestinal haemorrhage
has been reported. Impressive success rates have been
claimed. Compared to other methods of endoscopic
haemostasis, injection therapy has the advantage of
simplicity and economy. Sclerosants carry the risk of
tissue necrosis and perforation. The efficacy of
injecting adrenaline alone is unknown. More clinical
trials are needed to elucidate the place of injection
therapy in ulcer bleeding.
INTRODUCTION
Local injection of various agents has been used
extensively to stop bleeding from both ends of the
gastrointestinal tract. Injection sclerotherapy through
the rigid endoscope and more recently through the
flexible endoscope has been used successfully to control
variceal bleeding. Reductions in rebleeding rates and
prolongation of survival have been reported in
randomised trials (Macdougall et al 1982, Yassin
Sherif 1983). Injection sclerotherapy is now the first
line treatment for bleeding oesophageal varices in many
centers. Injection of phenol and other sclerosants is
a time-honoured method in, the treatment of bleeding
haemorrhoids. It is perhaps surprising that injection
treatment for the commonest cause of gastrointestinal
bleeding, namely ulcer bleeding, has received scant
attention until recently.
Several workers have reported the successful use of
injection treatment for non-variceal bleeding in
uncontrolled series. Agents used included absolute
alcohol, polidocanol, hypertonic saline mixed with
adrenaline, adrenaline followed by polidocanol,
thrombin, adrenaline followed by YAG laser, and
adrenaline followed by 98% alcohol.
POLIDOCANOL
Polidocanol is a sclerosant widely used in Europe
for oesophageal sclerotherapy. Its use in bleeding
gastric ulcers was first reported in 1976 (Soehendra and
Werner, 1976). Two cases of bleeding gastric ulcer, one
of which occurred 12 days after a Whipple's operation,
were successfully treated by submucosal injection 'of
1.5% polidocanol. Wordehof and Gros (1982) injected
polidocanol submucosally in 36 patients deemed to be at
high operative risk. Up to 20 ml were injected at one
sitting. Eleven patients had arterial spurters, 15 were
oozing and the other 10 had other stigmata. Thirty were
bleeding from peptic ulcers, 4 from Mallory-Weiss tears,
1 from carcinoma of stomach and one from a bleeding
papillotomy. Polidocanol injection accomplished
haemostasis in 33. Seven patients rebled, 3 of which
were controlled by repeat injection. No serious side
effects such as perforation or secondary haemorrhage
were reported. The authors did state, however, that
injection of larger volumes caused large superficial
ulcers and the local injury retarded healing.
ADRENALINE FOLLOWED BY POLIDOCANOL
Soehendra et al (1985) used the submucosal
injection of 5-10 ml of 1:10,000 adrenaline followed by
5 ml of polidocanol. They believed that adrenaline
caused the initial haemostasis by vasoconstriction and
compression. Definitive haemostasis was achieved by
vessel obliteration by polidocanol. Of 63 patients
injected, 22 had arterial bleeding, 28 were oozing, 8
had 'visible vessel' and 5 patients had other stigmata.
Of the patients with spurters, definitive haemostasis
was achieved in 16 after one injection. The other six
rebled and required a repeat injection. None required
emergency surgery. In those with oozing 22 stopped
bleeding after one session,r 6 required repeat injection
and 1 underwent emergency surgery. In the 8 patients
with visible vessels injection treatment was successful
with no recurrence.
The Soehendra technique (adrenaline followed by
polidocanol) was used in 56 patients with massive
bleeding in Toronto (Kortan et al 1986). Thirty two
patients had arterial spurting and the other 24 were
actively oozing. Injection treatment controlled 90% in
the spurting group and 100% of the oozing group. Only 4
patients underwent emergency surgery. No complications
attributable to the injections were reported.
In the only randomised controlled study of injection
therapy for bleeding ulcers, Panes et al (1987)
randomised 113 patients with active bleeding, visible
vessels and oozing clots to adrenaline injection
followed by polidocanol and no endoscopic treatment.
Three to 10 ml of adrenaline and 6- 12 ml of
polidocanol were used in the injection group.
Significant decreases in the rebleeding rate (5.5% Vs
43.1%), need for emergency surgery (3 vs 20 patients),
transfusion requirements (0.42 vs 2.7 units) and
hospital stay (11.6 vs 16.2 days) were demonstrated. No
major complications were reported. No data on extension
of ulcer or delay of ulcer healing were provided.
ABSOLUTE ALCOHOL
The use of local injection of absolute alcohol to
control gastrointestinal haemorrhage has been studied in
the laboratory (Asaki et al, 1983a) and in man (Asaki et
al 1983b). Submucosal injection of alcohol caused
immediate cessation of blood flow, followed by
thrombosis in the vessels and eventually ulceration. In
the clinical setting absolute alcohol was injected 0.1-
0.2 ml at a time around the bleeding point. 0.6-0.8 ml
were used for each lesion. Thirty cases of bleeding
caused by electrocautery and biopsy were successfully
controlled. Another 51 cases of spontaneous bleeding
were also treated. Forty four of these were bleeding
from ulcers (27 gastric, 13 duodenal, 3 gastric and
duodenal, 1 stomal). Haemostasis was achieved in all.
Three rebled and were controlled by reinjection. One
patient developed a perforation. Although the authors
cautioned against the extension of the ulcer from the
local effect of alcohol injection no data on this aspect
was provided. The single case of perforation occurred
in an area distant from the site of injection. The
authors ascribed the haemostatic effect to 'dehydration'
and 'fixation' of the tissues.
98% ETHANOL
Ninety eight percent dehydrated ethanol has been
used by Sugawa et al (1986) in 48 patients with massive
bleeding from the upper gastrointestinal tract (gastric
ulcer 17, duodenal ulcer 11 vascular ectasia 5, Mallory-
Weiss tear 3, erosions 6, marginal ulcer 1, leiomyoma 1
and carcinoma 1). Forty patients were actively bleeding
at the time of endoscopy, 10 of which from arterial
spurters. Ethanol injection was initially successful in
45. The three failures were among 10 patients with
pulsatile bleeding from visible vessels. Another 3
patients rebled in the group initially controlled. 14
operations (5 emergency and 9 elective) were performed.
HYPERTONIC SALINE-EPINEPHRINE MIXTURE
Hirao et al (1985) used a mixture of 3.6% or 7.1%
hypertonic saline mixed with 0.005% adrenaline and
injected 3 ml aliquots of the mixture 3-4 times around
the bleeding point. Repeat endoscopy was carried out 24
and 48 hours later and reinjection carried out if an
exposed vessel was still visible. One hundred and fifty
eight patients were studied. The great majority were
bleeding from ulcers (114 gastric, 15 duodenal, 5
marginal). One hundred and six of these patients have
exposed vessels. The mean transfusion was 1,666 ml.
Ninety three point seven percent achieved permanent
haemostasis (defined as no .rebleeding within 7 days) and
4.4% achieved temporary haemostasis (defined as
rebleeding within 7 days). With the institution of this
policy of injection treatment, the authors reported a
reduction of the rate of emergency operation from 21.7%
to 0.8%.
Chen et al (1986) compared the use of a mixture of
hypertonic saline and adrenaline and pure alcohol in 67
patients. In the hypertonic-saline-adrenaline group of
33 patients, 15 patients were actively bleeding
(pulsating 3, oozing 12). Permanent haemostasis was
achieved in 88%. In the 34 patients in the alcohol
group 14 were actively bleeding (pulsating 3, oozing
11). Permanent haemostasis was achieved in 91%.
THROMBIN
Fuchs et al (1986) used thrombin in 47 patients
with bleeding gastric or duodenal ulcers. One hundred
international units of thrombin was dissolved in 3 ml tof
0.9% saline and injection continued until the bleeding
stopped. This required about 10-15 ml of solution.
Initial haemostasis was obtained in 96%. Bleeding
recurred in 21%. The possibility of transmitting
diseases such as serum hepatitis and the acquired immune
deficiency syndrome is a potential risk.
ADRENALINE INJECTION FOLLOWED BY YAG-LASER
Disillusioned by the low success rate of YAG laser
therapy at their own center, Rutgeerts et al (1984)
injected 10 ml of 1:10,000 adrenaline around the ulcer
prior to the application of laser. This was done in 54
patients, 26 of whom had visible vessels and 28 non-
bleeding visible vessels. Adrenaline alone controlled
the bleeding in 12 out of 2 6 patients- with arterial
bleeding and markedly decreased the rate of bleeding in
the other 14. Bleeding was controlled in all but one
patient. Rebleeding developed in 7 patients, making an
overall success of 87%. The success rate of YAG laser
alone in the same unit was 40% prior to the
introduction of pre-treatment with adrenaline injection
(Rutgeerts et al 1982). The authors speculated that the
temporary haemostasis induced by adrenaline resulted in
better visibility and allowed more accurate targeting of
the laser beam. They also mentioned in passing a pilot
study on the injection of adrenaline alone. Of 15
patients with arterial bleeding or non-bleeding vessels,
only 4 achieved permanent haemostasis.
DISCUSSION
The results of injection treatment are impressive.
Close to 100% success has been claimed for various
agents. Although comparison between different series
which included various kinds of bleeding lesion is
difficult, the success of injection therapy is at least
as high as those claimed for other endoscopic methods.
The technique used in injection therapy was similar
in the reported series. The injected agent varied.
Sclerosants are used in most studies of injection
therapy. The ulcerogenic potential of sclerosant
injection was recognized by several authors who warned
against using excessive volumes (Asaki et al 1983,
Wordehof Gros 1982, Sugawa et al 1986). Local
complications were not reported in the clinical use of
these substances. There was one single incidence of
perforation with absolute alcohol in Asaki's series.
None of the authors, however, made a systematic study of
extension of ulcer size or delay of healing of injected
ulcers. Adrenaline injection has been used prior to
laser therapy (Rutgeerts et al 1984), mixed with
hypertonic saline (Hirao et al 1985, Chen et al 1986)
and prior to the injection of polidocanol (Soehendra et
al 1985, Kortan et al 1986, Panes et al 1987). The use
of adrenalin alone in this situation has not been
investigated.
Injection treatment has certain advantages over
other methods of endoscopic ulcer haemostasis. No
specialized equipment is necessary and the technique is
relatively simple to master. Unlike methods that
involve expensive apparatus and expert endoscopic
skills, injection therapy is likely to be widely
available in most hospitals that offer an endoscopic
service. The best agent to use in injection treatment
is yet to be identified. If the efficacy and safety of
injection therapy is confirmed, it may be the method of
choice for treating ulcer bleeding endoscopically.
(Schuman 1987).
PART IIS LABORATORY STUDIES
CHAPTER 5
ULCEROGENIC EFFECT OF INJECTABLE AGENTS:
AN ENDOSCOPIC STUDY IN DOGS.
SUMMARY
The effect of submucosal injection of various
agents were studied in the dog stomach. Method: Seven
mongrel dogs (15-20 kg) were anaesthetised by
intravenous thiopentone and anaesthesia maintained with
halothane and oxygen. Endoscopy was carried out using
an Olympus TGF-2S endoscope. Using the angula incisura
as landmark, 3 ml each of 100% alcohol, 3% STD, 5%
ethanolamine and 110,000 adrenaline Were injected
submucosally at different sites with a flexible needle
injector (Olympus NM-1K). The solutions were prepared
in labeled syringes, the endoscopist was not aware of
their nature during injection or subsequent assessment.
Repeat endoscopies were carried out 1 day, 3 days, 6
days and 10 days later. The size of ulcers, if any,
were measured with biopsy forceps. Results: Alcohol,
STD and ethanolamine produced ulcers at Day 1,
(diameter+SD: 2.8+1.0, 1.9+1.0, 1.8+1.0 cm
respectively). The ulcers decreased in size
progressively. At Day 10 the sizes were: alcohol
1.9+1.0, STD 0.9+ 1.0, ethanolamine 0.9+ 1.0 cm.
Adrenaline only caused superficial erosions.
Conclusion: In the concentration and volume used,
submucosal injection of sclerosant solutions causes
ulceration in the stomach whereas adrenaline injection
was non-ulcerogenic.
INTRODUCTION
Ulceration of the oesophagus is a common
complication of injection sclerotherapy of oesophageal
varices. Following the injection of sclerosants into or
around the varices, oesophageal ulceration results in
30-72% (Joffe 1984). Various sclerosants have been used
and ulceration has been associated with all of them.
There has been no comparative study on the efficacy or
ulcerogenic potential of the various agents in man.
The information concerning the ulcerogenic
potential of sclerosants injected into the stomach or
duodenum is even more scanty. Otani et al (1975) found
that ulcers could be consistently produced in the
stomach of the dog by the submucosal injection of 95%
alcohol. Indeed such injections were used to destroy
protuberant lesions such as polyps and elevated early
gastric cancer (Otani et al 1975). Asaki et al (1983)
studied the effect of absolute alcohol in the dog by
injecting the substance submucosally in the stomach
through a fibreoptic endoscope. Immediately after the
injection a white punctum developed with a dark red rim
which subsequently formed an ulcer. All lesions healed
after 4 weeks. No perforation developed. Sugawa et al
(1984) also confirmed the ulcerogenic potential of 98%
ethanol.
The submucosal injection of absolute alcohol (Asaki
et al 1983b), polidocanol (Wordehof Gros 1982),
adrenaline followed by polidocanol (Soehendra et al
1985, Kortan et al 1986, Panes 1987) and hypertonic
saline mixed with adrenaline (Hirao et al 1985) have
been used to stop ulcer bleeding in man. Success rates
of 90-100% were claimed. In none of these studies were
the ulcers serially examined for evidence of extension.
Asaki et al (1983b) reported one perforation with
absolute alcohol. Wordehof and Gros (1982) used 1%
polidocanol. Although no figures were given, they
mentioned that if the injections were too 'generous',
large superficial ulcers ;formed and healing would be
delayed. Sugawa et al (1986) limited his alcohol
injections to 0.8 ml and warned against the use of
excessive volume to avoid ulcer extension and
perforation.
Endoscopic injectioQof adrenaline were used in
combination with polidocanol (Soehendra et al 1985,
Kortan et al 1986, Panes et al 1987), with hypertonic
saline (Hirao et al 1985) and with Nd-YAG laser
(Rutgeerts et al 1984) in ulcer bleeding. The
administration of catecholamines caused gastric erosions
and ulceration in dogs (Nicoloff et al 1965).
Sethbhakdi et al (1970) found that the intraperitoneal
injection of 0.4 mgkg of adrenaline to pylorus-ligated
rats induced mucosal ulceration in the fundus in 100%.
This phenomenon was inhibited by bilateral vagotomy or
antacids in the stomach. The mechanism of ulcer
formation was thought to be related to a decrease in the
mucosal blood flow.
If local injection is to be used for ulcer
haemostasis, the ulcerogenicity of the agents injected
will have important bearing on the safety of the
technique. To investigate the ulcerogenic potential
of various sclerosants and adrenaline on the gastric
mucosa we studied the effect of submucosal injection of
these substances in the stomach of the dog. The
injection was made endoscopically and the stomach was
inspected at intervals by fibreoptic endoscopy.
METHOD
Mongrel dogs (weight 15-20 kg) were fasted overnight
and anaesthetised by intravenous thiopentone (50mgkg).
They were intubated and anaesthesia maintained by
halothane and oxygen. Endoscopy was carried out using
an Olympus TGF-2S operating gastroscope. Using the
angula incisura as landmark, 3 ml each of 100% alcohol,
3% sodium tetradecyl sulphate (STD), 5% ethanolamine and
110,000 adrenaline (David Bull) were injected
submucosally at 4 different sites. The injection sites
were selected at random. The injections were made with a
flexible needle injector (Olympus NM-1K) which has a 4
mm long needle with a 23 gauge diameter (Figure 1). The
solutions were prepared in numbered syringes, the
endoscopist was not aware of the nature of the solution
during injection or subsequent assessment. The sites of
injection were recorded in a diagram. Repeat
endoscopies were carried out under anaesthesia 1 day, 3
days, 6 days and 10 days later. The visual appearance
of the injected areas were noted and photographs taken.
The size of the ulcers, if any, were measured with
opened biopsy forceps. The experiment was repeated in
seven dogs.
Figure Is Endoscopic submucosal injection,
arrow indicates the flexible needle injector.
RESULTS
Submucosal injection of adrenaline gave a weal
which blanched immediately. Injection of absolute
alcohol resulted in a central white area surrounded by a
red rim. STD and ethanolamine resulted in a submucosal
weal only. Adrenaline resulted in superficial erosions.
None of the areas injected with adrenaline resulted in
frank ulceration. On subsequent examination, ulceration
was found in the areas injected with STD, ethanolamine
and absolute alcohol. The ulcers decreased in size
progressively with time. Ulcer size were identical with
STD and ethanolamine, but the ulcers induced by alcohol
injection were significantly larger (Figure 2). None of
the dogs developed overt haemorrhage or perforation.
The results are shown in Table 3. Endoscopic views of
the appearance of the area injected with adrenaline,
STD, ethanolamine and alcohol are shown in Figure 3, 4,
5 and 6 respectively.
Table 3: Effect of submucosal injection:
Endoscopic appearances
































Mean+ SD 1.9+1.4 1.4+1.3 0.8+1.1 0



































Mean+ SD 1.9+0.8 1.5+0.8 1.0+0.8 0.8+0.6

































Mean+ SD 1.8+0.7 1.4+1.3 1.0+0.6 0.5±0.£




































Mean+ SD 2.8+0.8 2.3+1.1 2.2+1.0 1.4+1.0
(Ulcer size shown in cm, indicates erosions)
Figure 2: Size of ulcers after submucosal injection
of sclerosants
Figure 3: Endoscopic appearances after submucosal
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Figure 4: Endoscopic appearances after submucosal
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Figure 5: Endoscopic appearances after submucosal
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Figure 6: Endoscopic appearances after submucosal
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DISCUSSION
The accurate identification of injection sites
endoscopically is of paramount importance to the
success of the study. We avoided the use of marker dyes
which may interfere with the visual interpretation of
the lesions and relied on the relative position in
relation to the angula incisura. The use of the angula
incisura as the endoscopic landmark identified 26 out of
28 injection sites. Only 2 sites were not confidently
identified at various times, either because of position
or food debris covering the area. The use of
anaesthesia made the identification of the sites
considerably easier. Movement of the dog is avoided,
the stomach can be fully distended and the animal can be
positioned to bring the area of interest into view.
To avoid observer bias, the agents were drawn up
into coded syringes. The endoscopist was not aware of
the nature of the injected substance at the time of
injection or on subsequent reassessment. The codes were
not broken until all the experiments were completed.
The effect of the various agents on the mucosa were
distinctive (i.e. blanching with adrenaline, white area
surrounded with a red rim with alcohol). It may be
argued that the endoscopist may be able to surmise the
nature of the injected agent from the effect it produced
on the mucosa and that subsequent observations were not
blinded. This criticism, however, does not detract
from the main conclusions drawn from this study.
The results of this experiment indicate clearly
that in the concentrations and volumes used, the
submucosal injection of STD, ethanolamine and absolute
alcohol resulted consistently in ulceration. Although
no frank bleeding or perforation resulted in any of the
dogs, the situation may be different when such agents
are injected into patients with bleeding ulcers. In
patients where the gastric or duodenal wall is already
weakened by existing ulceration the tissue necrosis
induced by the injected sclerosant may be dangerous and
cause frank perforation. Ulcer bleeding results from
erosion of submucosal or serosal arteries (Swain et al
1986). Further tissue damage and extension of the ulcer
caused by injected sclerosants may lead to erosion of
the thrombosed vessel. This may result in delayed
secondary haemorrhage.
Submucosal injection of 3 ml of 110,000 adrenaline'
did not cause frank ulceration in any one of our seven
dogs. Superficial erosion resulted in 5 dogs,
presumably as an effect of mucosal ischaemia due to the
vasoconstrictive effect of adrenaline. These rapidly
healed. Healing was complete in all dogs by the 10th
day. Because of its low ulcerogenic potential, 110,000
adrenaline seems to be a safe agent for endoscopic
submucosal injection and is worthy of further
investigation, particularly regarding its ability to
stop bleeding.
CHAPTER 6
HAEMOSTATIC EFFECT OF SUBMUCOSAL ADRENALINE INJECTION:
A STUDY USING STANDARD BLEEDING ULCERS
SUMMARY
The effect of submucosal adrenaline injection on
blood loss from standard bleeding ulcers was studied in
dogs. Mongrel dogs were anaesthetised using thiopentone
and anaesthesia was maintained with halothane and
oxygen. Laparotomy was performed and the stomach openeU
via an anterior gastrostomy. Submucosal injections of
3 ml of 110,000 adrenaline or 10% sodium metabisulphite
were made in the body of the stomach. Standard bleeding
ulcers were made in the injected area with the Quinton
ulcer-maker. Ulcers made in non-injected areas served
as controls. The blood loss in the first 3 minutes was
collected by inverting the ulcer over a small dish and
measured by weighing. Results: Mean blood loss from
control ulcers (n=25) in the first 3 minutes was 7.00+
5.54 gm (SD), injection of sodium metabisulphite (n=15)
caused no significant change( 6.26+ 2.40 gm) whereas
adrenaline (n=15) caused a significant decrease in the
blood loss( 2.87+ 1.86 gm, p 0.05).
Conclusion: Submucosal adrenaline caused a decrease in-
the blood loss from artefactual ulcers. Endoscopic
adrenaline injection may have a role to play in
endoscopic haemostasis.
INTRODUCTION
Evaluation of methods of endoscopic haemostasis in
the laboratory requires a reliable animal model of upper
gastrointestinal haemorrhage. The blood loss should be
reproducible and easily quantified and the model should
closely mimic the clinical situation of a bleeding
peptic ulcer.
The classical laboratory model for gastric ulcers,
the Shay pylorus-ligated rat (Shay, 1945) produces
perforating ulcers that do not bleed significantly.
Cold stress with restrain produce erosions in small
animals, but the bleeding rate is not predictable
(Brodie, 1962). Systemic administration of salicylates
(Bugat et al, 1975) and indomethacin (Watt Wilson
1959, Nicoloff 1968), or intra-mucosal injection of
ethanol (Otani et al, 1975) or acetic acid (Takagi et
al, 1969) also produce non-bleeding ulcers in animals.
These animal models are suitable for the investigation
of pharmacologically active agents in the prevention and
treatment of ulcers. They are not suitable as a model
of bleeding ulcer for evaluation of haemostatic methods.
The study of haemostasis in ulcers requires
reliably bleeding ulcers in larger animals such as dogs
so that blood loss can be easily measured. One model
involves multiple endoscopic biopsies of the gastric
mucosa (Dwyer et al, 1975). These lesions often stop
bleeding spontaneously and are not true ulcers because
they do not penetrate the muscularis mucosae. Cutting
across the gastric mucosa with scalpel or scissors
(Waitman et al, 1975) produces ulcers which vary greatly
in size and rate of haemorrhage. Pulling the gastric
mucosa through a snare and excising it with a cutting
current produces ulcers which do not bleed predictably
because of the inevitable coagulating effect of the
current. Grace and Gold (1975) described a technique of
excising a disc of mucosa overlying the left gastric
artery in dogs at laparotomy and then fenestrating the
wall of the artery. This produced profuse arterial
bleeding. This is a model of rapid exsanguination and
is perhaps more suitable for angiographic haemostasis
rather than endoscopic work, which depends on a clear
view of the bleeding point.
Portell et al (1976) described the use of the
ulcer maker in creating artefactual ulcers in
evaluation of methods of endoscopic haemostasis. This~
instrument uses a principle similar to that of the
Crosby intestinal biopsy capsule. It consists of an
outer capsule with a biopsy aperture, a cylindrical
cutting knife, and an internal obturator. When suction
is applied, gastric mucosa is sucked into the biopsy
aperture. A sharp pull on the guide wire causes the
cutting knife to slice through the gastric mucosa that
has prolapsed into the biopsy aperture (Figure 7). The
diameter of the internal obturator controls the
thickness of the gastric mucosa that can be sucked into
the capsule. The instrument can be used endoscopically
by attaching a 1.8 m long accessory guide wire within a
2.0 mm diameter protective sheath and back loading the
guide wire into the biopsy channel of a standard fibre-
optic endoscope. Portell et al (1976) found that the
most reproducible ulcers were made in the fundal area
with -14 inches of mercury of suction held for 1 sec
using a 8.1 mm diameter internal obturator. Ulcers were
of reproducible diameter and depth, extending into the
submucosa but not the muscularis externa. Without
heparinisation 7 of 12 ulcers continued to bleed after
30 minutes. With heparinisation (200 iukg stat and 100
iukghr) all ulcers continued to bleed beyond 70
minutes. The rate of bleeding from individual ulcers
varied from 0.3 to 22.4 ml in the first 3 minutes. By
grouping the ulcers according to their initial bleeding
rates, several haemostatic technigues could be tested in
each group.
One limitation of the ulcer maker is that the
bleeding produced by this method is from the submucosal
plexus of blood vessels. In patients with severe
haemorrhage from peptic ulcers the source of bleeding is
often a major blood vessel that has been eroded by the
ulcer. The artefactual ulcers probably bleed from
smaller blood vessels than a bleeding peptic ulcer.
Another drawback of the Portell artefactual ulcer is
that there is no fibrosis in the ulcer base. The
situation is therefore not entirely analogous to the
clinical bleeding peptic ulcer.
Be that as it may, the Portell ulcer maker is
currently the best laboratory model of a bleeding
gastric ulcer. It is the standard animal model used for
the study of endoscopic techniques. Methods of
endoscopic haemostasis evaluated in this way prior to
clinical use include electrocoagulation (Swain et al,
1984), Nd-YAG laser (Dixon et al, 1979), Argon and Nd-
Yag laser (Silverstein et al,' 1979), tissue glue
(Portell et al, 1978b) and the spraying of clotting
factors (Linscheer and Fazio, 1979).
METHOD
Mongrel dogs of 15-20 kg were fasted overnight.
Anaesthesia was induced using intravenous thiopentone
(50mgkg) given through a cannula in the forefoot vein.
The dog was then intubated and anaesthesia maintained
with halothane and oxygen. Blood pressure was monitored,
via an arterial cannula introduced through the femoral
artery. Hartmann's solution was given intravenously to
replace blood loss. Body temperature was monitored by a
rectal thermometer and maintained by a heating lamp.
Laparotomy was performed using a midline
epigastric incision. The stomach was identified and
opened via an anterior gastrostomy using diathermy.
Bleeding from the cut edges were controlled by non-
crushing intestinal clamps. Ulcers were created in the
body of the stomach using the Portell ulcer maker
(Figure 7). Each ulcer was placed at least 5 cm apart.
The ulcer-maker was placed on the mucosal surface
(Figure 8) and suction maintained at -14 inches of
mercury for 1 sec. The plunger was then sharply pulled
to cut off a disc of the mucosa. Blood loss was
measured for 3 minutes immediately after the creation of
the ulcer. This was done by inverting the ulcer over a
plastic dish (Figure 9). After 3 minutes the ulcer was
oversewn with 20 Dexon to prevent further blood loss.
Injection of 3 ml of either 110,000 adrenaline or
10% metabisulphite was carried out immediately prior to
the creation of the ulcers. The drugs were drawn up
into coded syringes and the order of injection was
randomised. The operator was not aware of the nature of
the drug during the injection, creation of the ulcer or
blood collection. The injections were made with 23
gauge needles inserted into the submucosa. Ulcers
created in areas without prior injection served as
controls. The diameter of the mucosal disc removed was
measured with calipers. The discs were then fixed in
formalin and examined histolpgically.
RESULTS
A total of 55 ulcers were created in 5 dogs. The
Portell ulcer-maker gave artefactual ulcers of
reasonably reproducible size. The diameter of the
excised mucosal discs measured 9.93+ 0.26 (SD) mm.
On histological sections, all the ulcers extended into
the submucosa but not to the muscularis externa (Figure
10).
The blood loss from 25 artefactual ulcers without
any injection treatment is shown in Table(4.1 The blood
loss in the first three minutes ranged widely from 1.16
gm to 26.10 grams. The mean blood loss in three minutes
was 7.00+ 5.49 gm (mean+ SD).
The blood loss after adrenaline and sodium
metabisulphite injection are shown in Table In the
adrenaline group (n=15) the blood loss in the first
three minutes ranged 0.24 to 6.66 gm. The mean blood
loss was 2.87+ 1.86 gm (mean+ SD). In the
metabisulphite group (n=15) the blood loss ranged from
0.40 to 15.22 gm. The mean blood loss was 6.25+ 4.40
gm (mean+ SD).
The blood loss in the three groups were compared
using unpaired Student's t tests. The adrenaline group
differed significantly from the controls (t= 2.72, p
0.05) and the metabisulphite group (t= 2.68, p 0.05).
There is no statistical difference between the control
group and the metabisulphite group (t= 0.37, p 0.05)
(Figure 11).
Figure 7: The Portell Ulcer-Maker
Wi{
Figure 8: The Ulcer-Maker placed on the gastric
mucosa prior to the creation of an
artefactual ulcer.
Figure 9: Blood collection from an artefactual ulcer.
Figure 10: Photomicrograph (H E section x 10) of an
artefactual ulcer. The ulcer extended into
the submucosa but not the muscularis externa.
Table 5: Blood loss (gm) in 3 minutes from
artefactual ulcers in the control group


























































































































































































































Figure 11: Blood loss in first 3 minutes from
artefacutal ulcers: controls, adrenaline























The rate of bleeding from the ulcers varied widely.
In 25 control ulcers the blood loss in the first 3
minutes ranged from 1.11 to 26.1 gm. This is comparable
to the range of blood loss reported by Portell in
heparinised dogs, which ranged from 0.3 to 22.4 ml in
the first 3 minutes (Portell et al 1976). The rate of
blood loss from the Portell ulcers depends on the size
of the submucosal blood vessels divided and therefore
varies from ulcer to ulcer.
Besides its well known vasoconstrictive action,
adrenaline is also a potent platelet aggregating agent
(O'Brien 1963). This property of adrenaline has been
used as a basis for the assessment of platelet function
in the laboratory (Dacie Lewis 1975). The formation
of a platelet plug may also contribute to the
haemostatic effect of locally injected adrenaline in
bleeding ulcers. Because of the possible effect of
adrenaline on the clotting system anticoagulants were
not used in our experiments. The blood loss in the
first 3 minutes in our control group in unheparinised
dogs was however somewhat more than that reported by
Portell et al (1976) in heparinised dogs (7.00+ 5.49 ml
vs 5.17+ 4.01 ml). The reason for this discrepancy
is not apparent.) The difference is, however, not
statistically significant.
In our initial experiments the artefactual ulcers
were first made and then injection of adrenaline carried
out into the ulcer base and edge in an attempt to
control the haemorrhage. This was found to be
unsatisfactory because the submucosa was already excised
by the ulcer-maker. There is no fibrous tissue in the
base of the artefactual ulcer to retain the drug, which
readily leaked out. Using the same technique,
Rutgeerts at al (1986) also found that adrenaline
injection was not effective in stopping bleeding from
Portell ulcers. This difficulty was overcome by
injecting the drug prior to the creation of the ulcer.
The drug diffused into the surrounding tissues and was
better retained.
The results of our experiment showed that injection
of adrenaline significantly decreased blood loss from
experimental ulcers, while the injection of the same
volume of the pharmacologically inert carrier did not
have any effect (Figure 11). The haemostatic effect of
adrenaline injection is therefore likely to be due to
its pharmacological action on the submucosal blood
vessels. Experimental ulcers made with the Portell
ulcer-maker differ in certain respects from bleeding
chronic ulcers. The bleeding from artefactual ulcers
comes from the mucosa and submucosa whereas the bleeding
from chronic ulcers comes from eroded blood vessels.
There is no fibrosis and scarring in an artefactual
ulcer. Caution must be exercised in extrapolating from
laboratory models to clinical situations. Even with
these limitations, we feel the results with adrenaline
injection is sufficiently encouraging to warrant further
investigation.
CHAPTER 7
EFFECT OF LOCAL ADRENALINE INJECTION
ON GASTRIC MUCOSAL BLOOD FLOW:
LASER DOPPLER VELOCIMETRY REFLECTANCE SPECTROPHOTOMETRY
SUMMARY
The effect of submucosal adrenaline injection
on gastric mucosal blood flow was studied in rats using
laser Doppler velocimetry and reflectance
spectrophotometry. The ability of the laser Doppler
apparatus to measure mucosal blood flow was validated by
measuring flow during coeliac artery occlusion. The
effect of submucosal injection of 0.1 ml of 110,000
adrenaline and 10% sodium metabisulphite (the carrier
substance of adrenaline) was compared using laser
Doppler velocimetry. Five rats were used in each group.
Adrenaline caused a rapid drop in gastric mucosal blood
flow to less than 10% of the basal value, which did not
show any increase for up to 120 minutes. Sodium
metabisulphite caused no significant change in mucosal
blood flow. The experiment was repeated using
reflectance spectrophotometry. Adrenaline caused a drop
in both the index of haemoglobin concentration (IHB) and
the index of oxygen saturation (IS02), which indicated
ischaemia without congestion. Metabisulphite caused no
significant change in either indices.
Conclusion: Local submucosal injection of
adrenaline causes a marked and prolonged decrease in
gastric mucosal blood flow without vascular congestion.
The vasoconstrictive effect of adrenaline is likely to
play a significant role promoting haemostasis.
INTRODUCTION
In Chapter 6 we demonstrated that injection of
adrenaline can decrease bleeding in experimental ulcers.
The mechanism by which injection treatment leads to
haemostasis remains unknown. Rutgeerts et al (1986)
claimed that the acute haemostatic effect depended
largely on the injected volume. Adrenaline is a potent
vasoconstrictor. Topically applied adrenaline has been
shown to cause vasoconstriction on the submucosal plexus
of the rat stomach (Guth Smith 1974). It is
reasonable to postulate that vasoconstriction may be an
important factor in mediating the haemostatic effect of
locally injected adrenaline.
In order to elucidate the mechanism of haemostasis
of locally injected adrenaline, we measured the changes
in gastric mucosal blood flow after local injection of
adrenaline and sodium meta-bisulphite, the carrier
substance of commercially available adrenaline.
METHODS OF MEASURING GASTRIC MUCOSAL BLOOD FLOW
Beaumont was the first to report changes in gastric
mucosal blood flow when he observed that the exposed
gastric mucosa of his patient Alex St. Martin changed
colour in different emotional states (Beaumont 1833).
The objective measurement of gastric mucosal blood flow
has been the subject of intensive studies in recent
years. Many ingenious methods of measuring gastric
mucosal blood flow have been described (Granger
Kvietys 1985). Measurement of the rapid change in blood
flow in a localized area of the stomach in response to
local injection poses certain problems. Gastric
clearance techniques, such as aminopyrine clearance
(Jacobson et al 1966) measures the blood flow to the
whole stomach. Injection of radioactively labeled
microspheres (Archibald et al 1975) allows blood flow to
specific areas of the stomach mucosa to be measured. By
using different isotopes to label the microspheres,
blood flow to the same area under different experimental
conditions can be compared. However the entrapment of
microspheres in the tissues depends on the relative
sizes of the microspheres and the vascular bed.
Manipulations which may change the caliber of the
vascular bed may cause migration of previously injected
microspheres (Maxwell et al 1982). Hydrogen gas
clearance, by utilizing a contact electrode against the
gastric mucosa, can measure blood flow in a specified
area (Leung et al 1984). However the blood flow needs
to be calculated from the half-time of the desaturation
current, making it unsuitable for continuous measurement
of the rapid changes in flow that is likely to occur
after injection of vasoactive substances.
Laser doppler velocimetry utilizes the principle
that light scattered by moving red blood cells undergoes
a shift in frequency. The magnitude of the shift in
frequency provides an estimate of the blood flow (Stern
1975, Ahn et al 1985). It can provide a continuous
measurement in a localized area and is therefore ideal
for measuring the change in mucosal blood flow after
local injection of substances. It cannot, however,
measure absolute flow in terms of mlmin, the flow rate
can only be given in terms of electrical units
(voltage). However, good co-relation between laser
doppler velocimetry and hydrogen gas clearance, which
measures absolute flow, has been demonstrated (Gana et
al 1986). For our purpose of comparing mucosal blood
flow after injection of adrenaline and its
pharmacologically inert carrier substance, the
measurement of absolute flow is not of paramount
importance. Another limitation of the laser Doppler
method is that constant coupling between the probe and
the tissue needs to be maintained. Any relative
movement between the two causes marked shifts in the
laser flux.
Reflectance spectrophotometry measures the tissue
absorption of reflected monochromated light at various
wave-lengths. Sato et al (1979) demonstrated that the
difference in relative absorbance 569 nm (isobestic
point of oxy- and deoxyhaemoglobin) and 650 nm (beyond
the haemoglobin absorption spectrum) bore a linear
relationship to the haemoglobin concentration in the
gastric mucosa. An index of haemoglobin concentration
(IHB) can be calculated. By spectral analysis of
reflected light at 569 ,577 and 586 nm, an index of
oxygen saturation (IS02) can also be determined. The
commercially available reflectance spectrophotometer
(Tissue Spectrum Analyser TS-200, Sumitomo Electric
Industries, Osaka, Japan) is connected to a
microcomputer data unit, which gives rapid
determinations of the IHB and IS02. Leung et al (1987)
used reflectance spectrophotometry to measure gastric
mucosal blood flow in the rat under different
experimental conditions. Ischemia without congestion
(e.g. haemorrhagic shock, coeliac artery occlusion) is
associated with a fall in the IHB and IS02, whereas
ischaemia with congestion (e.g. portal vein occlusion,
absolute ethanol-induced mucosal lesions) is associated
with a rise in the IHB and a fall in the IS02.
Reflectance spectrophotometry gives multiple readings at
different times in the same area. Rapid changes in
localized areas can be detected. In addition to changes
in blood flow, the presence of vascular stasis can also
be determined. Like laser Doppler velocimetry, absolute
flow cannot be measured.
METHOD
Experiment 1: Laser Doppler Velocimetry
Female Sprague-Dawley rats weighing between 400 and
450 grams were anaesthetised by intra-peritoneal
Nembutal (0.2 mgkg). The abdomen was entered via a mid¬
line incision. The fore-stomach was then opened with
scissors. The stomach was stabilized by placing it on a
perspex stage and the mucosa of the corpus of the
stomach was everted on a Q-tip (Figure 12). Mucosal
blood flow was measured using a laser Doppler flowmeter
(Perimed, Sweden, model Periflux) (Figure 13). The
laser probe was positioned perpendicular to the area of
mucosa in question using a micro-manipulator (Figure
14). The blood flow, expressed in terms of Doppler
flux, was continuously recorded by a strip-chart
recorder. Venous access was obtained by cannulating the
femoral vein. Throughout the experiment the rectal
temperature was monitored by a rectal thermometer and
kept constant by a heating lamp.
Figure 12: Inversion and stabilization of the
stomach mucosa on a perspex stage
Figure 13: Laser Doppler Velocimeter
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Figure 14: The laser probe positioned perpendicular
to the gastric mucosa.
Experiment la: Validation of the apparatus. A
coeliac axis occluder was made by heating a 5FG infant
feeding tube in boiling water and inflating it with a
syringe to obtain a bulbular tip. The tip was then bent
back on itself to make a inflatable occluder (Figure
15). The coeliac axis of the rat was isolated and the
occluder passed around it, making sure no kinking of the
artery was present. The laser Doppler probe was
positioned as described. After a stable baseline flow
was registered the occluder was inflated by injecting
air into it. The occlusion was held for 5 seconds and
then released. The experiment was repeated in 5 rats.
Figure 15: Coeliac axis occluder.
Experiment lb: Comparison of adrenaline and sodium
metabisulphite. The drugs (110,000 adrenaline, David
Bull and 10% sodium metabisulphite) were drawn up into
tuberculin syringes connected to 25 gauge Butterfly
needles. The needles were inserted into the loose
tissue layer between the mucosa and the muscle. The
laser probe was then placed directly over the area.
After a stable baseline flux was obtained for 5 minutes,
0.1 ml of the drugs were injected. The laser Doppler
flux was then continuously measured for 120 minutes, at
which time the rat was killed by intravenous Nembutal
overdose administered through the previously placed
femoral vein cannula. The laser Doppler flux recorded
after the animal died was taken as zero flow. The
experiment was repeated in 5 animals for each of the
substances studied.
Experiment 2: Reflectance spectrophotometry
The technique of reflectance spectrophotometry has
been validated by Leung et al (1987) in the same
laboratory using the same spectrophotometer. We
proceeded directly to the comparison of blood flow after
sub-mucosal adrenaline and meta-bisulphite injection.
Male Sprague-Dawley rats weighing between 150 and
200 grams were used. Arterial blood pressure was
monitored by carotid artery cannulation. Venous access
was obtained by cannulation of the femoral vein. Rectal
temperature was monitored with a temperature probe and
constant temperature maintained by a heating lamp.
Anaesthesia and preparation of the stomach mucosa were
identical to Experiment 1. The probe of the reflectance
spectrophotometer (Tissue Spectrum Analyser TS-200,
Sumitomo Industries, Osaka, Japan) (Figure 16) was
positioned perpendicular to the area of mucosa in
question using a micro-manipulator. The IHB and IS02
were continuously recorded. After a stable basal value
was obtained for 15 minutes 0.1 ml of the drug (110,000
adrenaline, David Bull, or 10% sodium meta-bisulphite
was then injected submucosally as described in
Experiment 1. The agents were drawn up into coded
syringes and the operator was unaware of their nature
during the experiment and the analysis of the results.
The measurements were continued for 120 minutes, at
which time the rat was killed by intra-venous Nembutal
overdose administered through the previously placed
femoral vein cannula. The IHB and IS02 values obtained
after the death of the animal were taken as tissue
blanks. Six rats were used for each of the agents
studied.
Figure 16: Reflectance Spectrophotometer
(Tissue spectrum analyser TS-200)
(Sumitomo Electric Industries, Japan)
Experiment la: A representative tracing of the
effect of coeliac axis occlusion on the mucosal blood
flow as measured by laser Doppler is depicted in Figure
17. There was a marked decrease in blood flow on
occlusion of the coeliac axis with a rebound increase to
above the baseline value on release of the occluder.
The results, expressed as percentage change from
baseline blood flow, are summarized in Table 6.
Student's paired t-test was used to compared the minimum
flow on occlusion and the maximum flow on release of the
occluder. The difference was highly significant (p
0.0005) (Figure 18).













Table 6 Percentage change in laser flux from baseline
value on occlusion and release of the coeliac
axis.

















Mean+ SD 27± 17 134+ 11
p 0.0005





















Experiment lb: Representative tracings of the
effect of locally injected adrenaline and sodium
metabisulphite are shown in Figure 19 and Figure 20
respectively. Adrenaline injection led to an immediate
and dramatic decrease in flow which lasted throughout
the experimental period. Death of the animal did not
lead to any measurable decrease in mucosal blood flow.
Sodium metabisulphite caused a transient drop in flow,
which rapidly returned to baseline. There was gradual
drop in flow throughout the experimental period. On
killing the animal, the laser flux dropped towards zero.
The change in blood flow in response to the two agents,
expressed as percentage change from baseline, are shown
in Table 7 and Figure 21. Unpaired Student's t-test
was used to compare the two groups. Highly significant
differences were demonstrated at 10, 30, 60, and 120
minutes after injection.
Figure 19: Effect of submucosal adrenaline injection on
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Figure 20: Effect of submucosal sodium meta—bisulphite
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Table 7 Percentage change in laser flux from baseline
value after submucosal injection of adrenaline
and sodium metabisulphite
Time fmin} 0 10 30 60 120
Adrenaline
(n=5) 100 9+6 6+4 6+5 10+6
Metabisulphite
(n=5) 100 113+14 94+9 76+19 64+14
P 0.0001 0.0001 0.0002 0.001
Figure 21: Comparison of the effect of submucosal
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Experiment 2: Representative tracings of the
effect of locally injected adrenaline and sodium
metabisulphite on the IHB and IS02 of the gastric mucosa
are shown in Figure 22 and Figure 23 respectively.
Adrenaline injection led to an immediate decrease both
IHB and IS02 which lasted throughout the experimental
period. Sodium metabisulphite caused a transient drop
in both parameters, which rapidly returned to baseline.
There was a gradual small drop both IHB and IS02 with
time. On killing the animal, the IS02 dropped to zero,
whereas IHB dropped to about 13 of the basal value.
The IHB reading after death (i.e. zero flow) was taken
as the tissue blank. The results of adrenaline and
metabisulphite injections, shown as IHB and IS02
readings, were shown in Tables 8 and 9 respectively.
The percentage changes in the two indices, expressed as
percentage change from baseline after deduction of the
tissue blank, were shown in Table 10 for adrenaline and
Table 11 for sodium metabisulphite. Comparison of the
mean percentage changes in IHB and IS02 are shown in
Figure 24 and Figure 25. Statistical analysis was
carried out using analysis of variance. The difference
between the two agents were highly significant (p
0.0001) for both IHB and IS02.
Figure 22: Effect of submucosal adrenaline injection on








0 1 2 3 4 5 60 120
MINUTES
Figure 23: Effect of submucosal sodium meta-bisulphite
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Table 8: IHB and IS02 after submucosal injection
of adrenaline
IHB




















































































Table 9: IHB and IS02 after submucosal injection
of sodium metabisulphite
IHB





















































































Table 10: Percentage change in IHB and IS02:
Effect of submucosal adrenaline
IHB



























































































Table 11: Percentage change in IHB and IS02:
Effect of submucosal sodium metabisulphite
IHB


























































































Figure 24: Comparison of the effect of adrenaline and
sodium metabisulphite on the IHB of






















0 10 30 60 120
MINUTES
Figure 25 Comparison of the effect of adrenaline and
sodium metabisulphite on the IS02 of
the rat gastric mucosa.
DISCUSSION
In Experiment la the change in mucosal blood flow
after mechanical occlusion of the coeliac axis was
measured. There was a marked decrease in laser flux
after the coeliac axis was occluded and a rebound
increase after the release of the occluder. ;This
indicated that laser Doppler velocimetry could reflect
changes in blood flow in our experimental set-up. In
Experiment lb the effect of local injection of
adrenaline and its carrier substance were compared using
the same apparatus. Adrenaline caused a dramatic drop
in the blood flow which did not show any tendency to
return to the base-line level for up to 120 minutes.
Sodium metabisulphite, the carrier substance, caused an
initial drop in flow immediately after the injection.
This rapidly returned to the basal level. Over a period
of two hours the flow gradually decreased. This
phenomenon was also observed in rats where no local
injection was given and was likely be due to the effect
of prolonged anaesthesia and exposure of the rat. In
pilot studies we found that beyond two hours anaesthesia
tended to be difficult. We therefore chose to terminate
our experiments at two hours.
Studies with reflectance spectrophotometry
(Experiment 2) showed that submucosal injection of
adrenaline led to a minor fall in the IHB and a highly
significant decrease in the IS02. These changes, as in
Experiment lb, persisted for up to two hours. No
significant change in either parameter was observed with
10% sodium metabisulphite. A gradual drop in both IHB
and IS02 was observed over two hours. This was
compatible with a gradual decrease in mucosal blood flow
as a consequence of exposure of the gastric mucosa and
anaesthesia. The decrease in both IHB and IS02 after
submucosal adrenaline injection was compatible with
ischaemia without congestion (Leung et al 1987) and
correlated well with our results in the laser Doppler
experiments.
Our results clearly indicated that local adrenaline
injection caused profound and prolonged decrease in
gastric mucosal blood flow and that the decrease in flow
was due to the pharmacological actions of adrenaline
rather that the mechanical effect of the injected
volume. The decrease in flow lasted for at least two
hours which allowed ample time for thrombosis to occu.
Peptic ulcers bleed from eroded arteries rather than
from the mucosal capillaries. Guth and Smith (1974)
have shown by in vivo microscopy that mucosal blood flow
is controlled by the submucosal arteriolar network and
not by the mucosal microvessels. The submucosal plexus
is highly sensitive to the vasoconstrictive effect of
adrenaline. Oren-Wolman Guth (1984) demonstrated that
the larger sized vessels in the submucosa are equally
sensitive to adrenaline. The decrease in mucosal flow
observed in our study is likely to be due to the effect
of the submucosally injected adrenaline on the larger
vessels in the submucosa rather than the mucosal
capillaries. The results of our experiments strongly
suggest that the vasoconstrictive effect of submucosally










Endoscopic injection of adrenaline was performed in
37 patients with actively bleeding ulcers. Initial
haemostasis was achieved in all. Five patients rebled
and 3 required emergency surgery. No local or systemic
complication was observed.
INTRODUCTION
Endoscopic injection of adrenaline has been used in
combination with other haemostatic modalities to control
bleeding in the upper gastrointestinal tract. Soehendra
et al (1985) injected adrenaline prior to the injection
of polidocanol. Other authors (Kortan et al 1;986,
Panes et al 1987) also used this technique with success.
Rutgeerts et al (1984) used adrenaline injection prior
to Nd-YAG laser photo-coagulation and improved the
success rate from 40 to 87%. Hirao et al (1985) used a
mixture of 110,000 adrenaline and hypertonic saline to
control bleeding from bleeding lesions in the upper
gastrointestinal tract. The use of endoscopic
adrenaline injection alone in treating bleeding ulcers
has not been reported.
Our laboratory studies, discussed in Part II,
suggest that local adrenaline injection in the stomach
is non-ulcerogenic, decreases blood loss from
experimental ulcers and decreases gastric mucosal blood
flow by vasoconstriction. The effect of submucosal
injection of adrenaline lasts for at least 2 hours.
These studies suggest that local submucosal injection of
adrenaline alone may be adequate in stopping bleeding
from peptic ulcers. Using adrenaline alone has the
advantage of simplicity and safety. The possible
dangers of ulcer extension, delay of healing and
perforation associated with the use of sclerosants may
be avoided by using adrenaline injection alone.
Patients with stigmata of recent haemorrhage
without active bleeding such as non-bleeding visible
vessels have been included in most studies on endoscopic
haemostasis. The likely mechanism of haemostasis with
adrenaline injection is vasoconstriction and possibly
platelet aggregation. The wisdom of prophylactically
injecting ulcers with a thrombosed artery is uncertain.
We have, therefore, decided to only include patients
with active bleeding seen at the time of endoscopy in
our pilot study.
PATIENTS
The study period extended from November 1984 to
October 1985. During this period a total of 593
patients with upper gastro-intestinal haemorrhage were
admitted to the Prince of Wales Hospital, Hong Kong.
This accounted for 4.8% of all emergency admissions to
the hospital. Of these 593 patients, 403 (68%) were
found to have ulcer-related bleeding. Thirty-nine
patients (9.6%) were actively bleeding at the time of
endoscopy. The bleeding point could not be accurately
identified in two patients because of torrential
bleeding. They underwent emergency surgery and were
excluded. The other 37 patients were included in the
study. Patient with non-bleeding visible vessels, (i
adherent clots covering the ulcer base and no stigmata
of recent haemorrhage were not injected. Patients with
contact bleeding only were also excluded.
Of the 37 patients with active bleeding, 29 were
male and 8 were female. Their age ranged from 15 to 79
(mean age= 48 years). Thirty patients had a previous
ulcer history and 16 had a documented bleed in the past.
Eleven patients had significant medical problems;
chronic obstructive pulmonary disease 4, ischemic heart
disease 3, chronic renal failure 2, diabetes 1, gross
obesity 1, ruptured aortic aneurysm 1 and hemiplegia 1.
Eight patients were hypotensive on admission
(systolic blood pressure below 100 mm Hg). The mean
haemoglobin on admission was 9.8 gdl (range 5- 14.9).
Twenty seven patients were bleeding from duodenal ulcers
and 10 were bleeding from gastric ulcers. Twelve
patients were bleeding from an arterial spurter (defined
as pulsatile bleeding) and 25 were oozing (defined as
continuous but non-pulsatile bleeding which persists
after washing).
ENDOSCOPY
Emergency endoscopy was performed within 24 hours
of admission after resuscitation. For those with signs
of active bleeding or remain hypotensive despite blood
or fluid replacement, emergency endoscopy was carried
out as resuscitation was in progress. The procedure was
performed under intravenous diazepam (5-10 mg).
Occasionally hyoscine bromide was used to reduce gastric
motility during injection.
TECHNIQUE OP INJECTION
An end-viewing endoscope (Olympus GIF-Q) and a
flexible needle injector (Olympus NM-1K) were used. The
endoscope has a channel of 2.8 mm diameter. The needle
was 23 gauge and projected for 4 mm from the sheath.
Gastric lavage was not used routinely, but in patients
with a lot of blood or clots in the stomach an overtube
system was used to wash out the stomach (Cotton 1983).
Blood or clots covering the ulcer were washed away using
a modified water tooth brush (Chung Leung 1987).
Aliquots of 110,000 adrenaline was injected into and
around the bleeding point until the bleeding stopped.
The ulcer was observed for 5 minutes after injection
before removal of the endoscope.
POST-ENDOSCOPY MANAGEMENT
The patient was returned to the surgical gastro¬
enterology ward and monitored for signs of rebleeding.
Upper endoscopy was carried out 24 hours later to assess
the state of the ulcer and stigmata of recent
haemorrhage. H2 blockers were given intravenously
initially. When oral feeding was resumed oral H2
blockade was commenced. After discharge, follow up
endoscopy was carried out at 4 weekly intervals until
the ulcer healed.
RESULTS
The results are summarized in Table 12. Bleeding
was controlled with local adrenaline injection in all 37
patients at the time of endoscopy. Endoscopic
photographs of three patients before and after the
procedure are shown in Figures 26, 27 28. The total
volume of adrenaline used ranged from 1.5 ml to 10 ml
(mean= 4.1 ml). No local or systemic complications
were observed. Five patients (three with duodenal
ulcers and two with gastric ulcers) rebled 4 hours to 4
days after the procedure. One stopped spontaneously,
one responded to repeat adrenaline injection and three
underwent successful emergency surgery. Thirty one
patients required blood transfusion, ranging from 1 to
12 units (mean, 5 units). Two patients died, neither as
a consequence of bleeding. One patient developed
bleeding in the intensive care unit from a gastric ulcer
after surgery for a ruptured aortic aneurysm. The
bleeding was controlled by adrenaline injection, but the
patient died of multi-organ failure 6 weeks later.
The other patient died of a stroke 1 month after his
bleeding episode. On follow up of the remaining 32
patients, 29 had healed ulcers 4-12 weeks later. Three
patients did not return for follow up.
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Figure 26: Gastric ulcer with arterial spurter
before (left) and after (right)
adrenaline injection.
BBBmM;B •fc |J M
Figure 27: Gastric ulcer with spurter before (left)
and 24 hours after (right) injection
Figure 28: Oozing duodenal ulcer before (left) and
after (right) adrenaline injection
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DISCUSSION
The present study is the only report of the use of
local adrenaline injection alone in ulcer haemostasis.
Unlike other reports on endoscopic treatment of upper
gastrointestinal bleeding only actively bleeding ulcers
were included in this study. Most endoscopists would
refer the patient for immediate operation if active
bleeding is demonstrated during endoscopy. Indeed in a
randomised trial on Nd-YAG laser, Rutgeerts (1984)
excluded patients with active arterial bleeding from his
control group on ethical grounds. We were impressed by
the 100% success of local adrenaline in stopping the
bleeding at the time of endoscopy. The rebleeding rate
was gratifyingly low. Only 5 out of 37 patients rebled
and only 3 needed emergency surgery. The success rate
of adrenaline injection is comparable to those reported
with the use of sclerosants and adrenaline followed by
sclerosants.
Endoscopic injection of adrenaline was singularly
free from side effects. No perforation or delayed
haemorrhage was observed. We routinely endoscoped the
patients 24 hours later. No extension of the ulcer was
observed. The healing rate of the injected ulcers on H2
blocker treatment is comparable to the reported healing
rate for ulcers that presented with bleeding (Murray et
al 1986). No significant arrhythmia or serious cardio-
vascular event was observed. Catecholamines have an
significant first pass extraction by the liver (LaVeen
et al 1972). It is unlikely that adrenaline injected
submucosally into the stomach or duodenal wall will
reach the systemic circulation in significant amounts.
Technically local adrenaline injection has certain
advantages over other endoscopic techniques. Electro¬
coagulation, heater probe and laser photo-coagulation
require the lesion to be washed clear of blood and clot
prior to their application. This is not always possible
when there is active bleeding or a sentinel clot.
Injection treatment can'be carried out through covering
blood or clot provided a momentary view of the bleeding
point can be obtained. Adrenaline injected close to the
bleeding vessel decreases the rate of bleeding, allowing
a better view and more accurate placement of the needle
in subsequent injections.
On the basis of this pilot study it was decided to
proceed to a randomised clinical trial.
CHAPTER 9
ADRENALINE INJECTION VS CONSERVATIVE TREATMENT
A RANDOMISED TRIAL
SUMMARY
A prospective randomised trial was performed to
assess the efficacy of adrenaline injection in actively
bleeding ulcers. Emergency endoscopy in 961 patients
admitted for upper gastrointestinal haemorrhage
identified 68 patients with actively bleeding ulcers.
They were randomised to receive either endoscopic
adrenaline injection or no endoscopic treatment. After
endoscopy both groups were managed in identical manner.
Strict criteria for emergency surgery were adhered to in
both groups. Bleeding was initially controlled in all
34 patients assigned to the injection group. The
control group received significantly more blood (5 units
vs 3 units, p 0.05), needed emergency surgery more
often (41% vs 15%, p 0.02) and stayed in hospital
longer (8 days vs 6 days, p 0.005).
Conclusion: Adrenaline injection is effective in
stopping bleeding from actively bleeding ulcers.
TWTPnnTTPTTnN
The results of our pilot study (Chapter 8) were
encouraging. Initial haemostasis was obtained in all 37
patients at the time of endoscopy. Only 13.5% rebled
and only 8% required emergency surgery. However it must
be remembered that 80% of patients with ulcer bleeding
will stop spontaneously. Although only patients with
active bleeding were included in our pilot study, it may
be argued that all patients with haematemesis or melaena
must, at some point in time, be actively bleeding. The
demonstration of active bleeding may just be a
reflection of the timing of the emergency endoscopy. It
is impossible to estimate what proportion of those 37
patients would have stopped bleeding spontaneously if
adrenaline injection had been withheld.
The likelihood that bleeding from a peptic ulcer
will stop spontaneously is so high that no technique for
stopping the haemorrhage can be judged clinically useful
unless validated by a controlled trial (Young 1982).
For meaningful results to be obtained large numbers of
patients need to be recruited. The Prince of Wales
Hospital is a large teaching hospital in an area where
ulcer bleeding is very common. All patients with
gastrointestinal bleeding are processed through a single
unit (Chapter 2). The environment is ideal for
conducting randomised therapeutic trials of ulcer
haemostasis. A large number of patients can be
collected within a reasonable period of time in a single
institution, avoiding the difficulties of conducting a
multi-centered trial (Tedesco 1981).
TRIAL DESIGN
Emergency endoscopy: All patients admitted to the
Prince of Wales Hospital, Hong Kong with upper
gastrointestinal haemorrhage were endoscoped within 24
hours of admission. Patients who were shocked or
bleeding massively were endoscoped as soon as they were
resuscitated. When blood clots in the stomach obscured
the view, stomach lavage was carried out using an
overtube system (Cotton 1973). Blood clots and coffee
ground material covering the ulcer base were washed away
using a modified water pump (Chung Leung 1987).
Trial inclusion and randomization: All patients
with actively bleeding ulcers were included. Patients
with contact bleeding only, non-bleeding visible
vessels, blood clots covering the ulcer base with no
active bleeding and no endoscopic stigmata of recent
haemorrhage were excluded.
Randomization into injection treatment and control
groups were carried out at the time of endoscopy. A
sealed numbered envelope containing the treatment
option, which was determined by a random number list
generated by computer, was opened. Ulcers with an
arterial spurter (pulsatile bleeding) and oozing (non¬
pulsatile bleeding which persists after washing) are
stratified separately.
Injection: The technique of endoscopic adrenaline
injection was described previously (Chapter 8). Using a
flexible needle injector (Olympus NM-1K) inserted
thorough the biopsy channel of the endoscope, aliquots
of 0.5 ml of 110,000 adrenaline was injected into and
around the bleeding point until the bleeding stops.
Forward viewing endoscopes (Olympus GIF-Q, GIF-QIO GIF-
1T10, GIF-2T10) were used routinely. Side viewing
endoscopes (Olympus JF-1T) were occasionally used for
difficult lesions.
After endoscopy: All patients were returned to the
surgical gastroenterology ward for observation. They
were given intravenous H2 blockers (Cimetidine 400 mg 6
hourly or Ranitidine 150mg 6 hourly). Blood pressure
and pulse were monitored hourly. Central venous
pressure monitoring was used in those over 60 years of
age, those with cardiac disease and those who has had a
massive bleed. Haemoglobin was measured daily. Blood
transfusion was given to maintain the haemoglobin level
above 10 gmdl. Repeat endoscopy was carried out 24
hours later. Repeat adrenaline injection was carried
out for patients in the injection group if active
bleeding was again seen.
Emergency surgery: The need for emergency surgery
was determined by two experienced surgeons, one of whom
ishot involved with the injection treatment. Identical
criteria for emergency surgery were strictly adhered to
for both the injection group and the control group.
Emergency surgery was performed if any one of the
following conditions was satisfied: 1) failure of the
blood pressure or pulse to stabilize after four units of
blood, 2) a total transfusion of more than eight} units
of blood, 3) a rebleed as evidenced by haematemesis or
red naso-gastric tube aspirate associated with
tachycardia andor hypotension.
Trial indices: The injection and control groups
were compared for 1) transfusion requirement, 2)
emergency surgery, 3) ,hospital stay and 4) hospital
mortality. Statistical evaluation was carried out using
the Chi-squared test and the Median test.
RESULTS
From November 1985 to December 1986 961 patients
underwent emergency endoscopy for acute gastrointestinal
haemorrhage. Sixty eight patients with actively
bleeding ulcers were identified and entered into the
study. The bleeding lesion could not be identified in
two patients. One of them was found to have an aorto-
oesophageal fistula at autopsy, the other was found to
be bleeding from a gastric varix at operation.
The patient characteristics of the two groups are
shown in Table 13. They are comparable by age, sex,
location of ulcer.and severity of bleeding.
The results are summarized in Table 14. in the
injection group, adrenaline injection controlled the
bleeding in all 34 patients. The volume of adrenaline
used ranged from 3-14 ml (mean 6.8 ml). At repeat
endoscopy 24 hours later 6 patients were found to be
bleeding again (one spurting, 4 oozing). Repeat
injection controlled the bleeding in all 6. Five
patients underwent emergency surgery 6, 16, 34, 48 and
48 hours after endoscopy. Indications for surgery were
haemodynamic instability after 4 units of blood, 1
patient; transfusion over 8 units, 2 patients, and
clinical rebleeding; 2 patients Three patients
satisfied more than one criteria. The median blood
transfusion requirement was 3 units (range 0 -12
units).
In the control group 14 patients underwent
emergency surgery, 4 within 6 hours of endoscopy, 4
between 6 and 25 hours, 2 at one day, 3 between 3 and 5
days and 1 at 10 days after endoscopy. The indications
for surgery were: unstable after 4 units, 7 patients?
transfusion over 8 units, 3 patients; rebleeding, 4
patients. Four patients satisfied more than one
criteria. The median blood transfusion requirement was
5 units (range 0-25 units).
On statistical analysis, the difference in
transfusion requirement was significant (p 0.02, one-
tailed Median test). The difference in emergency
surgery was also significant (p 0.05, Chi-squared
test).
Elective surgery: Two patients in each group
underwent elective ulcer operations 7-10 days after
their first endoscopy because of multiple episodes of
bleeding in the past. None had shown any evidence of
rebleeding prior to surgery.
Hospital stay: The hospital stay ranged from 3-
27 days (median= 6 days) in the injection group and 4-
108 days (median= 8 days) in the control group. The
difference is statistically significant (p 0.005, one-
tailed Median test).
Mortality: There were 3 hospital mortalities in
the injection group (heart failure on Day 1, post¬
operative pneumonia on Day 5, renal failure on Dy 23)
and 2 deaths in the control group (pneumonia on Day 5,
hepato-renal failure on Day 3 0). The difference was not
significant statistically.
Ulcer healing: Twenty one patients in the
injection group and 14 patients in the conservative
group returned for endoscopy 6 weeks after discharge.
Complete ulcer healing was demonstrated in 81% (17
patients) of the injection group and 79% in the
conservative group. The difference was not significant
statistically.
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In clinical trials on gastrointestinal bleeding
various end points can be used to determine the success
or otherwise of treatment (Langman 1985). The most
unequivocal end-point is mortality. With modern
management in a specialized unit the mortality rate for
bleeding ulcers is under 10%. In most cases the cause
of death is co-existing irreversible medical conditions
rather than exsanguination. In our present series of
patients with active bleeding, there were 5 deaths in 68
patients, giving a mortality rate of 7.3%. It is
unlikely that a difference in mortality can be
demonstrated in a trial of reasonable size.
Other end-points include rebleeding rates,
transfusion requirements, need for emergency surgery and
length of stay in hospital. Rebleeding may be difficult
to define clinically. It may be impossible to
distinguish from continued bleeding. Although
haematemesis associated with hypovolaemic shock leaves
no doubt that active bleeding has just occurred, the
diagnosis of a smaller rebleed may be equivocal.
Melaena may be passed days after the bleeding episode.
Drop in the haemoglobin level may be due to
haemodilution. Transfusion requirements and emergency
surgery are also determinants that may be influenced by
clinical judgment. The length of hospital stay may be
affected by unrelated social factors.
Our study was conducted in 1986 during the early
phases of the establishment of our teaching hospital.
Due to the shortage of experienced endoscopists and
gastrointestinal surgeons it was impossible to perform
the trial as a blinded study. Often the therapeutic
endoscopist and surgeon was the same person. To avoid
difficulties of interpretation and to avoid bias, we
drew up a set of objective and unequivocal criteria for
transfusion and emergency surgery. These criteria were
strictly adhered to. Because of the difficulties of
diagnosing rebleeding, this was not used as one of the
end-points. Instead, unequivocal rebleeding
(haematemesis and shock) was included as one of the
criteria for emergency surgery.
The present study confirms in a randomised
controlled manner our earlier experience that adrenaline
injection is effective and safe. As in our pilot study
initial haemostasis was achieved in all 34 patients in
the injection group. The overall success rate of
injection treatment, as judged by the number of patients
that needed emergency surgery to stop bleeding, were
comparable to that observed in the pilot study (534
patients in the randomised study, 337 patients in the
pilot study). No complication was observed. There was
no extension of ulcer on repeat endoscopy at 24 hours
and the healing rates with H2 blocker treatment in the
control and injection groups were identical. The
injection group received significantly less blood,
needed emergency surgery significantly less often and
required a shorter hospital stay.
Data on the natural history of an actively bleeding
ulcer is scanty because most patients with active
bleeding either undergo endoscopic haemostasis or are
referred for emergency surgery. Scrutiny of the control
group in our trial throws some light on the natural
history of an actively bleeding lesion seen at
endoscopy. In our control group of 34 patients with
active bleeding 41% (70% of spurters, 29% of oozers)
required emergency surgery. This compares with a
emergency surgery rate of 8.1% in our bleeding ulcer
patients overall. Our data is in agreement with
Brearley et al (1985) who claimed that active bleeding
at the time of endoscopy represents a poor prognostic
factor. Active bleeding seen at endoscopy identifies a
high risk group in which future studies on endoscopic




The ideal endoscopic method for ulcer haemostasis
should be simple, inexpensive, safe, portable and
effective. Laboratory and clinical studies described in
this thesis indicate that adrenaline injection therapy
fulfills these criteria. Comparative studies with other
modalities of endoscopic haemostasis should be carried
out.
Endoscopic haemostasis is likely to become the first
line treatment in controlling ulcer bleeding.
Experienced endoscopists and assistants, careful
monitoring of patients during and after the procedure,
good clinical judgement and close liaison between
endoscopists and surgeons are essential for endoscopic
haemostasis to be successfully applied.
THE IDEAL ENDOSCOPIC METHOD FOR ULCER HAEMOSTASIS
The advent of therapeutic endoscopy heralds a new
era in the treatment of bleeding ulcers. It is
unnecessary to approach the bleeding point in the
stomach or duodenum by laparotomy when endoscopic Recess
through the mouth is so readily available. Endoscopic
haemostasis should be the first line treatment for
patients who require intervention to stop bleeding from
ulcers. Surgery being reserved for those in whom
endoscopic haemostasis is unsuitable or unsuccessful.
The best haemostatic modality to use is still an
open question. Techniques which involve expensive,
highly specialized equipment are likely to be limited to
major teaching centers only. The majority of patients
presenting with upper gastrointestinal bleeding will be
admitted to district general hospitals. Those who
continue to bleed are unlikely to be fit for transfer to
a major teaching centre. To decrease the overall
mortality of upper gastrointestinal bleeding, an
endoscopic method must be readily available in most
hospitals and within the technical capability of most
endoscopists.
As discussed in Chapter 3 mechanical methods such
as tissue glue and clips have proved ineffective. Laser
photocoagulation involves expensive and delicate
equipment, is difficult to use even in expert hands and
is no more effective than the thermal methods. Its
place in therapeutic endoscopy is likely to be in the
palliative treatment of obstructing tumours rather than
haemostasis.;
The ideal method should be simple, inexpensive,
safe, effective and can easily be brought to the bedside
if necessary. Endoscopic injection therapy requires no
additional equipment other than a flexible sclerotherapy
needle• It can be carried out without using large
channel therapeutic endoscopes. It certainly has the
advantages of availability, simplicity and portability.
The injection can be carried out even if the bleeding
point is covered with blood, provided a momentary view
of the bleeding point can be obtained by irrigation. It
is perhaps surprising that so little interest has been
shown in its use in ulcer bleeding.
This thesis describes studies of the safety,
efficacy and mechanism of action of injection treatment
for ulcer bleeding. The safety of injection therapy was
first studied in the laboratory. Studies in dogs
(Chapter 5) have shown that sclerosants injected
submucosally led to severe ulceration, whereas
adrenaline injection did not lead to ulceration.
Although other workers have used sclerosants, albeit in
smaller volumes, in bleeding ulcers with apparently
good results, the undoubted ulcerogenic potential of
sclerosants made them less than ideal for injection
therapy. Attention was concentrated on the possible use
of adrenaline, a potent vasoconstrictor. The ability of
submucosally injected adrenaline to control bleeding was
studied in experiments using bleeding artefactual ulcers
in the canine stomach (Chapter 5). Adrenaline caused a
significant decrease in the rate of blood loss,
indicating that it may be useful in controlling ulcer
bleeding. The mechanism of action of submucosal
adrenaline was then studied in the rat stomach by
measuring the changes in mucosal blood flow using laser
Doppler velocimetry and reflectance spectrophotometry
(Chapter 6). A profound decrease of blood flow with no
vascular congestion, which lasted for at least two
hours, was detected after adrenaline injection. The
carrier substance of adrenaline did not alter the
mucosal blood flow significantly. These results
suggested that the vasoconstrictive effect of adrenaline
may be important in controlling ulcer bleeding.
These laboratory studies suggest that submucosal
injection of adrenaline may be useful in stopping
bleeding from peptic ulcers. Supported by these
laboratory data, a pilot clinical study was carried out
on patients with actively bleeding ulcers (Chapter 8).
Thirty seven patients with actively bleeding ulcers seen
at the time of endoscopy were treated by endoscopic
adrenaline injection. The bleeding was successfully
controlled in all 37 at the time of endoscopy. No
complications were observed. The rebleeding rate was
13.5% and only 3 patients needed emergency surgery.
These results were most encouraging and led us to
perform a randomised trial comparing adrenaline
injection against conventional treatment (Chapter 9).
Significant reduction in transfusion, emergency surgery
requirement and hospital stay were demonstrated in
favour of injection. The safety of adrenaline injection
was confirmed in the clinical studies. None of our
patients, either in the pilot study or in the randomised
trial, developed complications as a result of injection
treatment. No extension of ulceration was observed and
ulcer healing was not delayed.
The newer thermal methods, e.g. the Heater probe
and the BICAP probe are close contenders with injection
therapy. They have a built-in wash channel for clearing
the lesion of blood clot prior to application. In
addition there is the possibility of applying pressure
before heat is applied. This coaptive coagulation may
lead to a tighter seal of the coagulated vessel. These
devices cost around HK$ 100,000. Although expensive,
they are within the budget of most regional hospitals.
The more effective large diameter probes however require
special large channel therapeutic endoscopes. The BICAP
probe has been shown to be clinically useful in two
randomised controlled trials (Laine 1987, O'Brien 1986).
The early results of another trial in Los Angeles
suggest that the heater probe is at least as good as
the BICAP (Jensen, personal communication). Comparative
studies of these probes against injection therapy is
certainly indicated. One such trial, comparing the
heater probe against adrenaline injection in actively
bleeding ulcers, is currently in progress in our unit.
rHERAPEUTIC ENDOSCOPY IN ULCER BLEEDING
The use of therapeutic endoscopy as the first line
treatment for upper gastrointestinal bleeding represents
a major change in current practice. Its widespread
adoption is likely to create certain logistic problems.
Emergency endoscopy in patients with bleeding
ulcers is more difficult and potentially more hazardous
than routine diagnostic endoscopy. Blood and clots tend
to obscure the endoscopic view and the danger of
aspiration is ever present. Therapeutic manoeuvers to
stop bleeding require additional endoscopic skills.
These procedures are certainly not for the inexperienced
trainee assisted by untrained endoscopy assistants.
Although most procedures can be performed during the
daylight hours when experienced staff are available,
there will be occasions when the rate of bleeding is
such that the procedure needs to be performed outside
working hours. For the efficient running of an
endoscopic haemostasis service an emergency rota of
experienced endoscopists is essential. Few units can
afford, or indeed have the volume of work to justify 24
hours nursing staff support. In emergencies nursing
support has to be recruited from elsewhere, either from
the gastrointestinal ward, the operating theatre or the
intensive care unit. These personnel need to be trained
in the proper handling of the endoscope and accessories,
and in the care of an acutely ill patient undergoing
what may be a difficult and prolonged endoscopic
procedure.
An endoscopy unit which undertakes to offer
therapeutic endoscopy for bleeding must be prepared for
patients who may be unstable and require active
resuscitation during the procedure. Facilities for
rapid transfusion and monitoring must be easily to hand
and the staff must be conversant with their use.
Electrocardiographic monitoring and equipment for
endotracheal intubation and cardiopulmonary
resuscitation are the absolute minimum. Continuous
blood pressure monitors and transcutaneous oximetry may
allow deterioration in the patient's condition to be
detected before fatal complications result.
A dilemma that the therapeutic endoscopist must face
is choosing which patients to treat. Over 80% of
patients with ulcer bleeding stop bleeding
spontaneously. A non-selective policy would subject a
large number of patients to unnecessary treatment. It
would seem logical that all patients with active
bleeding should be treated. The outcome in the control
group of our randomised trial supports this view. In
this group of patients who have active bleeding at the
time of endoscopy but received no endoscopic therapy 41%
(70% of patients with spurters, 29% of patients with
oozing) required emergency surgery eventually. The case
for 'prophylactically' treating non-bleeding visible
vessels is less clear cut. The incidence of rebleeding
in these patients ranged widely in the literature (see
Chapter 1). Whilst all authors agree that ulcers
without stigmata rarely rebleed, the probability of
rebleeding in an ulcer with stigmata remained
controversial. Although restarting haemorrhage has not
been reported with injection therapy, treatment of a
visible vessel with laser (Krejs et al 1987) or
electrocoagulation (O'Brien et al 1986) can occasionally
cause major haemorrhage. if both clinical and
endoscopic data are taken into account, the likelihood
of rebleeding can be more accurately predicted.
Bornman et al (1985) found that 79% of patients who had
shock and exhibited important stigmata rebled. It may
be reasonalble to offer endoscopic treatment to these
patients to decrease the chance of recurrent
haemorrhage.
No matter how effective endoscopic haemostasis may
be, there will be instances when it will fail. Surgery
still remains the most definitive method of stopping
the bleeding. Patients who would have been operated
on previously are now managed by non-operative methods.
The endoscopist must avoid persisting with endoscopic
treatment and deferring operative intervention until the
eleventh hour. The indications for surgery for patients
who have undergone endoscopic haemostasis have not been
clearly defined. Our policy at present is to offer
emergency surgery without delay if 1) severe bleeding
obscures the bleeding point, 2) active bleeding cannot
be controlled or 3) rebleeding occurs after apparently
successful endoscopic treatment. It must also be
remembered that unlike surgery, endoscopic methods do
not influence the ulcer diathesis. Patients with a long
ulcer history and significant ulcer complications in the
past should be offered definitive surgery within the
same hospital admission if they are fit for surgery.
Patients who are unfit for surgery should be considered
for life long maintenance H2 blocker therapy, as they
may not survive another significant bleed.
Close co-operation between gastroenterologists and
gastrointestinal surgeons is essential for good results
in managing patients with upper gastrointestinal
bleeding. The lowest mortality rates are reported from
combined units where the patients are under the joint
care of gastroenterologists and surgeons. Co-operation
between the endoscopist and gastrointestinal surgeon is
of paramount importance if therapeutic endoscopy for
bleeding is undertaken. The demarcation between
gastroenterology and gastrointestinal surgery is
becoming increasingly blurred with the advent of
therapeutic endoscopy. Combined gastrointestinal units
will be the trend in the future. If obstacles in
training and career structures can be overcome we may
even see an amalgamation of the two specialties.
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